molecular mechanisms of NCX1 and NCX3-induced neuroprotection in anoxic brain preconditionoing by Sisalli, Maria Josè
1 
 
UNIVERSITA’ DEGLI STUDI DI NAPOLI "FEDERICO II" 
 
FACULTY OF MEDICINE, DIVISION OF PHARMACOLOGY 
SCHOOL IN MOLECULAR MEDICINE 
 
PhD PROGRAM IN NEUROSCIENCE  
XXIV CYCLE  
 
“MOLECULAR MECHANISMS OF NCX1 AND 
NCX3-INDUCED NEUROPROTECTION IN 
ANOXIC BRAIN PRECONDITIONOING” 
 
TUTORS:                                                                                    PhD STUDENT: 
Prof. Gianfranco Di Renzo                                                          Dr. Maria Josè Sisalli 
Prof. Antonella Scorziello 
 
COORDINATOR: 
Prof. Lucio Annunziato 
2010-2011 
2 
 
SUMMARY 
INTRODUCTION                                                                        p. 4 
   - Pathophysiology of ischemic damage 
   - Ischemic Preconditioning 
   - Experimental model of ischemic preconditioning 
                  - In vivo models 
                 - In vitro models 
   - Molecular mechanisms activated by ischemic preconditioning 
                 - Role of Nitric oxide (NO) 
                 - Role of heat shock proteins (HSPs) 
                 - Role of inflammatory cytokines 
                 - Role of the anti-apoptotic protein Bcl-2 
                 - Role of adenosine A1receptors and ATP-sensitive K
+channels 
                 - Role of opioid receptors 
                 - Role of the ubiquitin proteasome pathway 
                 - Role of autophagy/lysosomal pathway 
 
 
3 
 
                 - Role of hypoxia inducible factor-1 (HIF-1) 
                 - Cellular ionic homeostasis and energy metabolism 
 
AIM OF THE STUDY                                                              p. 62 
 
MATERIALS AND METODS                                                  p. 66 
   - Primary cortical neurons 
   - Combined oxygen and glucose deprivation (OGD) 
   - Western Blot                                                                              
   - Imaging of mitochondrial [Ca 2+] and mitochondrial membrane potential                
   - [Ca 2+]i measurment                
   - Determination of cell death: Propidium iodide/Fluorescein assay                             
   - Determination of mitochondrial function: MTT assay                                                      
   - Materials 
   - Small interfiring RNA against NCX1 and NCX3 
   - Statistical analysis 
 
4 
 
RESULTS                                                                              p. 73 
 Effect of ischemic preconditioning on neuronal survival of cortical neurons 
exposed to OGD/reoxy 
 NCX1 and NCX3 protein expression after ischemic preconditioning in cortical 
neurons exposed to OGD/reoxygenation 
 Akt activation in cortical neurons exposed to IPC 
 NCX1 and NCX3 expression after LY294002 and L-NAME treatment in 
cortical neurons exposed to IPC 
 NCX activity after ischemic preconditioning in cortical neurons exposed to 
ogd/reoxygenation 
 [Ca2+]m in cortical neurons treated with sirna against NCX3 and exposed to 
OGD/reoxygenation 
 Mitochondrial function in cortical neurons treated with CGP and exposed to 
IPC followed by OGD/reoxygenation 
 Effect of ischemic preconditioning on neuronal viability of cortical neurons 
treated with siRNA against NCX1 and NCX3 and exposed to 
OGd/reoxygenation 
 
DISCUSSION                                                                         p. 89 
 
REFERENCES                                                                       p. 92 
5 
 
INTRODUCTION 
 
The term ischemia (Greek iskhein to keep back + haema or hema blood) 
means a restriction in blood supply to a bodily organ or tissues. Interruption 
of blood flow to the brain, or part(s) of the brain, is known as cerebral 
ischemia or stroke. There are two different kinds of stroke: haemorrhagic or 
ischemic. Hemorrhagic stroke is due to the rupture of a cerebral artery 
because of the increase of blood pressure; ischemic stroke, that is far more 
common, is due to a deficit of cerebral blood flow. 
The stroke is a medical emergency, which can cause permanent neurological 
damage, complications, and death. Stroke causes 9% of all deaths around 
the world, is the third most common cause of death after ischemic heart 
disease and cancer, and may soon become the leading cause of death 
worldwide. It is the leading cause of adult disability, since 76% of people in 
the United States and Europe survive their stroke (American Heart 
Association; 2008). 
Representing stroke one of the three leading causes of death and the major 
cause of long-term disability makes it and its therapy, one of the major 
challenges facing contemporary medicine. In order to reduce the 
consequences of this disease, and to develop therapeutic strategies aimed to 
reduce neuronal damage, the medical research has to conduct experiments 
to highlight the cellular, biochemical and molecular mechanisms involved in 
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neuronal damage. Nowadays, there are no effective therapeutic protocols 
able to induce significant improvement of ischemia-induced brain damage, 
and all clinical trials conducted in the eighties and nineties were ineffective in 
the clinical treatment of stroke. The only FDA-approved treatment for acute 
cerebral ischemia is rTPA, which has demonstrated to cause a improvement 
in long-term outcomes. However, only a small percentage of patients with 
ischemic stroke are treated with rTPA due to its narrow therapeutic window 
and contraindications to thrombolytic therapy. 
Thrombolytic therapy does not directly interfere with the ischemic cascade, 
but changes the cellular and molecular environment that induces it. Neuronal 
damage often continues with restored blood flow to areas. New therapies 
based on the understanding of the complex interactions of the ischemic 
cascade may eventually increase the therapeutic window for salvage of the 
penumbra and provide direct neuroprotection. Combination treatment with a 
neuroprotective drug or multiple drugs and thrombolytic therapy might 
theoretically improve stroke outcomes, but this hypothesis requires 
confirmation in clinical trials. Potentially, patients at risk of ischemic stroke 
could receive prophylactic treatment with a neuroprotective drug, either 
extending the window for thrombolytic efficacy or decreasing the damaged 
area. The prevention of oxidative damage with novel free radical trapping 
agents may be effective in improving outcome by reducing disability caused 
by ischemic stroke. Such agents may be efficacious both as a stand-alone 
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treatment in view of the efficacy seen in models of permanent ischemia in 
several species, as well as when used as adjuncts to thrombolytic therapy. A 
combination treatment approach may, in addition to reducing the damage 
due to ischemia, also reduce reperfusion injury, which may be caused by the 
deleterious effects of oxygen radical species produced when oxygenation is 
restored to the ischemic brain (Weinberger, 2006). 
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PHYSIOPATHOLOGY OF ISCHEMIC DAMAGE 
 
The ischemic process is due to a complex series of pathophysiological 
events triggered by a decreased supply of oxygen and glucose in the 
cerebral tissue which requires, for a smooth running, large amounts of these 
two molecules. The cerebral energy production, given the scarcity of glucose 
deposits and other macromolecules available for anaerobic pathways of ATP 
production, depends almost entirely on the good operating of the 
mitochondrial oxidative chain. 
The main pathogenetic mechanism involved in the genesis of ischemic injury 
seems to be excitotoxicity, peri-infarct depolarization, oxidative stress, 
inflammation, intracellular ionic dysregulation. In fact, altered Ca2+ 
dysregulation, triggering Ca2+-dependent bio-polymer degradation and 
mitochondrial and bioenergetic failure, ultimately culminates in the activation 
of reactions leading to necrotic/apoptotic cell death. The ischemic cell death 
is due to changes directly related to the inhibition of oxidative 
phosphorylation. These modifications include pH reduction, ATP decrease, 
production of free radicals from the mitochondrial chain, increase in [Na+]i. 
The energetic depletion determines the block of Na+/K+ ATPase and Ca2+ 
ATPase lying to a reduction of neuronal and glial membrane potential 
(Katsura et al., 1994) (Figure 1).  
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Figure 1: Physiopathology of ischemic damage 
 
This kind of depolarization, called ―anoxic depolarization‖ as it occurs some 
minutes after the stimulus anoxic/ischemic, determines both the activation of 
voltage gated Ca2+ channels (VOCC) and an inversion in the operation mode 
of the Na+ depending transporters, such as the Na+/Ca2+ exchanger activated 
in reverse mode of operation. These modifications determine a massive 
entrance of Ca2+ into the cell with a consequent increase of its concentration, 
critical for the genesis and perpetuation of the ischemic damage. Indeed, this 
ion is able to activate enzyme and metabolic pathways potentially 
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detrimental, to induce the release of neurotransmitter such as glutamate, and 
to inhibit oxidative mitochondrial chain. 
Glutamate is the most common excitatory neurotransmitter in the central 
nervous system and many functions of the brain occur through the release of 
this mediator in the synapses. Therefore, an alteration of glutamatergic 
neurotransmission seems to be responsible for different diseases, including 
them the ischemic neuronal death. In neurons, glutamate is stored in 
synaptic vesicles by a vesicular transmitter which uses, as energy source, a 
H+ gradient created by the vesicular proton pump. This excitatory 
neurotransmitter is released from the presynaptical terminal after the Ca2+ 
entrance and acts both on presynaptic and postsynaptic receptors, which are 
ionotropic as AMPA, NMDA e kainate, and metabotropic.  
The glutamate extracellular concentrations briskly rise during acute brain 
injury since its presynaptical Na+ dependent transporter is blocked by the 
anoxic depolarization and consequent rising of [Na+]i induced by ischemic 
insult.  
The metabotropic glutamate receptors are coupled to a Gq protein and their 
stimulation activate phospholipase-C that, through the production of inositol 
triphosphate (IP3), mobilizes calcium from intracellular stores contributing to 
further increasing on its concentrations. Therefore, there is a continuous 
"release to release" of glutamate, followed by entry of Ca2+ and Na+ into the 
cell and consequent damage and cell death. 
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These findings have led to the elaboration of the paradigm of glutamate 
excitotoxicity that explained ischemic neuronal cell death as a mere 
consequence of Na+ and Ca2+ influx through glutamate receptors. Although 
this theory has been guiding basic research in the field of neurodegeneration 
for almost 3 decades, more recently it has become the object of serious 
criticism and reassessment. What has aroused such skepticism among 
researchers has been the fact that although first, second, and third 
generation glutamate receptor antagonists have long yielded promising 
results in animal models of brain ischemia, they have failed to elicit a 
neuroprotective action in stroke and traumatic brain injury in humans. 
Therefore, the theory of excitotoxicity, though a fascinating paradigm, can 
only explain some of the events occurring in the acute phase of anoxic insult 
but cannot be seen as a major target for developing new therapeutic avenues 
for brain ischemia.  
Increasing evidence suggests that there may exist mechanisms of 
neurotoxicity that operate independently of, or in parallel with, excitotoxicity. 
Indeed, during ischemia, neuronal calcium channels and transporters 
(including NCX, TRM2, TRPM7, ASICS, CaV1.2 and hemichannels) as well 
as glutamate receptors (NMDAR, AMPAR, KAR) are overactivated. The 
increased activity of plasma membrane Ca2+ channels can then trigger the 
entry of Ca2+ into the cytosol of neurons, leading to larger than usual 
increases in the cytosolic calcium concentration. Ca2+ ions may gain access 
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to the neuronal cytoplasm via ion channels or Ca2+ transport systems, or 
through the release of Ca2+ ions from intracellular stores (Figure 2) 
(Szydlowska et al., 2009).  
 
 
 
Figure 2: Routes of calcium entry into neurons after ischemic injury 
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Depletion of calcium ions from the endoplasmic reticulum (ER) has been 
suggested as an initial signal for ER dysfunction in ischemic neurons 
(Paschen et al., 1999). Many studies indicate that a strong release of calcium 
ions from ER is associated with damage to cells, including damage to 
neurons after ischemia (Pisani et al., 2000). Chen et al. reported that 
dysregulation of Ca2+ER homeostasis following ischemia involves two 
phases: accumulation of Ca2+ in ER stores and subsequent release of Ca2+ 
from ER following ischemia/reoxygenation (REOX) (Chen et al., 2008). 
NKCC1 and NCXrev are involved in Ca2+ ER dysregulation, which includes 
overload of Ca2+ into ER during oxygen and glucose deprivation (OGD) and 
release of Ca2+ from ER during REOX (Chen et al., 2008). Ca2+ ER release is 
largely mediated by IP3R activation during early REOX (Bruno et al., 2001). 
Inhibition of NKCC1 during OGD prevented Ca2+ ER accumulation. This 
occurs because NKCC1-mediated Na+ flux may trigger Ca2+ influx through 
NCXrev and contributes to Ca2+ ER loading (Chen et al., 2008). It has been 
suggested that IP3R-mediated ER Ca2+ release can enter the adjacent 
mitochondria and trigger cytochrome c release (Rizzuto et al., 2006). 
Consistent with an elevation of NCX activity and in accordance with normal 
cytosolic calcium concentrations, Sirabella et al. found that during OGD an 
increased refilling of Ca2+ into ER occurred (Sirabella et al., 2009). NCX1 
upregulation occurred following OGD and may play a fundamental role in ER 
Ca2+ refilling thus preventing ER stress and cell death during OGD.  
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As well as endoplasmic reticulum, mitochondria sense and shape cytosolic 
Ca2+ signals by taking up and subsequently releasing Ca2+ ions during 
physiological and pathological Ca2+ elevations. 
Mitochondria contain two membranes, an outer membrane permeable to 
solutes and an inner membrane impermeable to solutes that harbours the 
respiratory chain complexes. The respiratory chain pumps protons against 
their concentration gradient from the matrix of the mitochondrion into the 
inter-membrane space, generating an electrochemical gradient in the form of 
a negative inner membrane potential and of a pH gradient, the matrix being 
more alkaline than the cytosol (Bernardi, 1999; Poburko et al., 2011). The 
electrical and chemical components of the proton-motive force add up to 
energize the back-flux of protons down their electrochemical gradient across 
the ATP synthase, the enzyme that generates ATP. The negative 
mitochondrial membrane potential (ΔΨm) used to drive the entry of protons 
also favors the entry of calcium, a divalent cation, into the mitochondrial 
matrix. As a result, mitochondria can accumulate large amounts of calcium 
through a Ca2+-selective channel known as the mitochondrial Ca2+ uniporter 
(MCU) (Kirichok et al., 2004; Nicholls et al., 2000). The MCU has a relatively 
low Ca2+ affinity, Kd~10 mM in permeabilized cells (Bernardi, 1999), but Ca2+ 
uptake can be readily detected in intact cells because a significant fraction of 
mitochondria are located close to calcium release or calcium entry channels 
and therefore exposed to microdomains of high calcium concentrations 
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(Giacomello et al., 2010; Rizzuto et al., 1993; Pacher et al., 2002). 
Electrophysiological recordings of mitoplasts, small vesicles of inner 
mitochondrial membrane, revealed that the MCU is a highly Ca2+-selective 
inward-rectifying ion channel (Kirichok et al., 2004).  
Instead, Ca2+ efflux from mitochondria is catalyzed by antiporters that drive 
Ca2+ out of the mitochondrial matrix in exchange with Na+ or H+ (Nicholls and 
Crompton, 1980). Two types of exchangers have been functionally 
characterized in the 1970s, the Na+/Ca2+ and the H+/Ca2+ exchangers; the 
former is particularly abundant in excitable tissues (Carafoli, 2003). These 
two pathway have been defined Na+-independent pathway for Ca2+ efflux 
(―NICE‖) and Na+-dependent pathway for Ca2+ efflux (―NCE‖) respectively. 
They have different kinetic of activation and calcium affinity (Harris, 1979; 
Lehninger et al., 1978; Ramachandran and Bygrave, 1978). Another 
mechanism responsible of mitochondrial calcium efflux is represented by 
mPTP. 
Although the Na-dependent Ca2+ efflux is characteristic of excitable cells, 
recent observations indicate that the mitochondrial Na+–Ca+ exchanger 
(mNCX) plays and important role in the control of [Ca2+]c also in non-
excitable cells, since the mNCX inhibitor CGP37157 blunts oscillations 
induced by G-protein coupled agonists (Hernández-SanMiguel 2006). 
Located in the inner mitochondrial membrane, the mNCX mediates the efflux 
of Ca2+ from the mitochondria coupled to the influx of Na+, with a 
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stoichiometry of 3Na+/2Ca2+ (Pfeiffer et al., 2001; Saris and Carafoli, 2005). 
This implies that the exchanger is electrogenic because it transports an 
excess of positive charge into the matrix. In respiring mitochondria, the 
relative membrane depolarization, caused by the activity of the exchanger, is 
compensated by proton pumping through the respiratory chain. As for most 
ion transporters of the inner mitochondrial membrane, identity of these 
proteins has been long searched. Only recently has the NCLX exchanger, a 
member of the NCX family, been hypothesized to be expressed and localized 
in the inner membrane of mitochondria (IMM) (Palty et al., 2010). This Li+ 
sensitive protein localized within the cristae, is both phylogenetically and 
functionally distinct from NCX and NCKX family members (Palty et al., 2010). 
These authors also showed that NCLX participates to the mitochondrial 
Na+/Ca2+ exchanger activity. However, the molecular mechanisms involved in 
NCLX expression, transport, localization, as well as its role in mitochondrial 
activity regulation still remain unidentified. On the other hand, the analysis of 
mitochondrial DNA does not reveal the presence of genes encoding for 
proteins belonging to the family of the Na+/Ca2+exchanger, suggesting that 
OMM and the IMM do not possess their own endogenous proteins operating 
as a Ca2+efflux/influx pathway. Therefore, it is conceivable that a member of 
the NCX family, coded by nuclear DNA, might be present on mitochondria, as 
it occurs for the majority of mitochondrial proteins (Stojanovski, 2003). 
Indeed, 90% of mitochondrial proteins are coded by nuclear genes, 
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synthesized in the cytosol, and, subsequently, imported into mitochondria 
through protein translocation machineries of the outer and inner membranes 
(Stojanovski, 2003). More recently, our group provided evidence that the 
nuclear encoded NCX3 is the only isoform of the Na+/Ca2+-exchanger 
localized within the OMM, where it plays a relevant role in the control of 
mitochondrial Ca2+ homeostasis both under basal and under hypoxic 
conditions. This novel finding is not in contrast with the results of Palty et al, 
since it possible to hypothesize that the Na+/Ca2+ exchanger in mitochondria 
requires two consecutive steps. The first, operated by the Na+-sensitive 
NCLX, mediates Ca2+ transport from the matrix to the intermembrane space, 
and the second, operated by mNCX3, that promotes Ca2+ efflux from the 
intermembrane space to the cytosol. This interpretation is in line with the 
recent physiological role attributed to the OMM in the control of mitochondrial 
Ca2+ cycling. Indeed, although the outer surface of the membrane is not a 
passive permeable membrane, it does constitute a permeability barrier not 
only to Ca2+ influx but also to Ca2+ efflux (Szabadkai and Duchen, 2008). On 
the other hand, evidence that mNCX3 is involved in Ca2+ extrusion is that the 
Ca2+ lowering effect found in cells transfected with NCX3 was completely 
prevented by the benzothiazepine compound CGP-37157, which is 
considered a selective mitochondrial Na+/Ca2+exchanger inhibitor (Szabadkai 
and Duchen, 2008). 
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The Na+-independent Ca2+ efflux is the main mitochondrial Ca2+ efflux 
system in non-excitable cells and since no specific cations have been found 
to be exchanged with Ca2+ it is believed to be a Ca2+–H+ exchanger (Saris et 
al., 2005). This transport mechanism requires transmembrane potential, 
since it is not observed in non-energized mitochondria, thus indicating that it 
is not an electroneutral passive 1Ca2+–2H+ exchanger (Gunter et al., 1991). 
Indeed, this system is able to extrude Ca2+ against a gradient that is much 
higher than predicted from thermodynamics for an electroneutral H+/Ca2+ 
exchanger, which indicates that it uses a component of the electrochemical 
gradient for its activity. A characteristic of this transporter is that it saturates 
at low calcium loads and its kinetics is extremely slow (Bernardi, 1999). This 
emphasizes a feature of the mitochondrial Ca2+ machinery: it is equipped 
with high Vmax uptake transport systems coupled to slow and easily 
saturable release systems, increasing the risk of Ca2+ overload. 
As discussed above, cytosolic Ca2+ elevations are rapidly transmitted to the 
mitochondrial matrix, where they amplify the activity of Krebs cycle enzymes 
and of the ATP synthase, thereby increasing the production of ATP (Denton 
et al., 2009; Jouaville et al., 1999). During physiological Ca2+ elevations, the 
boost of ATP enables PMCA to extrude the cytosolic calcium and to sustain 
neuronal activity. During ischemia however, the levels of oxygen and glucose 
drop rapidly, impairing the production of ATP by mitochondria and by 
cytosolic glycolysis. As a result, ATP dependent calcium extrusion 
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mechanisms progressively come to a halt because the intracellular reservoir 
of ATP is depleted by the continuous activity of the Na+/K+ ATPases. The 
importance of the Na+/K+ ATPases in ―stealing ― ATP from PMCA could be 
directly demonstrated as PMCA activity, which collapsed during metabolic 
depletion, could be rescued by inhibition of the Na+/K+ ATPases (Castro et 
al., 2006). PMCA inhibition amplifies the cytosolic calcium elevations that are 
transmitted to the mitochondrial matrix, and can then triggers a vicious 
sequence of mitochondrial calcium overload, mitochondrial dysfunction, 
release of mitochondrial pro-apotpotic factors, and the activation of death 
signals (Starkov et al., 2004; Duchen, 2004; Kristian et al., 1998). 
Mitochondria located near the plasma membrane (subplasmalemmal 
mitochondria) are more exposed to calcium overload due to their proximity to 
plasma membrane voltage-sensitive calcium channels and to the functionally 
incapacitated PMCA (Frieden et al., 2002; Frieden et al., 2005; Jousset et al., 
2007). Intracellular mitochondria are also at risk however, and calcium 
release from the endoplasmic reticulum has been associated to ischemia 
induced-cell damage (Paschen et al., 1999; Pisani et al., 2000; Chen et al., 
2008). Mitochondria are embedded within sheets of endoplasmic reticulum 
and the two organelles are maintained in very close proximity by linker 
proteins (Csordas et al., 2010; Csordas et al., 2006). Because of this 
proximity, the release of calcium ions through IP3 receptor of the 
endoplasmic reticulum readily triggers an entry of calcium in adjacent 
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mitochondria (Giacomello et al., 2010; Rizzuto et al., 1993). Thus, neuronal 
mitochondria are exposed both to Ca2+ ions entering across membrane 
channels and to Ca2+ released from endoplasmic reticulum Ca2+ stores. 
Currently, it is unclear whether the mitochondrial matrix Ca2+ elevations 
occurring during ischemia are causally related to the neuronal cell death that 
occurs after cerebral ischemia. The best established link between 
mitochondrial Ca2+ and cellular toxicity is the opening of a Ca2+-activated 
channel located in the inner mitochondrial membrane, the permeability 
transition pore (PTP) (Halestrap, 2009; Rasola et al., 2007, Zoratti et al., 
2010), responsible for the so-called mitochondrial permeability transition 
(MPT). The MPT (Zoratti et al., 1995) is a phenomenon induced by high 
levels of matrix Ca2+ accumulation and oxidative stress, responsible for a 
sudden increase in the mitochondrial inner membrane permeability to solutes 
with molecular masses up to 1500 Da. The PTP is a Ca2+, ROS (reactive 
oxygen species), voltage-dependent and Csa sensitive high- conductance 
channel, located in the inner mitochondrial membrane. Despite the great 
interest generated by this channel, which has been extensively characterized 
at the pharmacological and biophysical level, the molecular identity of the 
PTP is not known. The classical model envisions a supramolecular complex 
spanning the double membrane system of mitochondria, localized at contact 
sites (Brdiczka et al., 1998). Proteins of all mitochondrial compartments have 
been proposed to be part of the PTP (Halestrap, 2009; Rasola et al., 2007; 
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Zoratti et al., 2005), in particular cyclophilin D (CypD) in the mitochondrial 
matrix, the adenine nucleotide translocator in the inner membrane and 
mitochondrial porin VDAC in the outer membrane. Surprisingly, genetic 
studies have demonstrated that MPT can still be observed in mitochondria 
devoid of each of these proteins (Basso et al., 2005; Kokoszka et al., 2004; 
Krauskopf et al., 2006). Some other proteins, including inter-membrane and 
cytosolic proteins and even the proapoptotic Bcl-2 family protein Bax, have 
been proposed to be part of the PTP under particular conditions (Marzo et 
al., 1998; Narita et al., 1998), but Ca2+-dependent MPT was shown to be 
independent of Bax (De Marchi et al., 2005). Although the proteins 
responsible for this important mitochondrial process have not yet been 
identified, the generation of CypD-knockout mice has now established an 
unquestionable role for CypD in facilitating PTP opening (Basso et al., 2005; 
Baines et al., 2005; Nagakawa et al., 2005; Schinzel et al., 2005; De Marchi 
et al., 2006). The biophysical properties (conductance, voltage-dependence, 
selectivity) of PTP were indistinguishable in mitochondria isolated from 
isogenic wild-type and engineered mice lacking CypD (De Marchi et al., 
2006), but CsA only inhibited the PTP in wild-type mice (Basso et al., 2005; 
De Marchi et al., 2006), demonstrating that CypD represents the target for 
PTP inhibition by CsA. That the permeability transition is triggered by an 
elevation in the free Ca2+ concentration within the mitochondrial matrix was 
discovered early (Haworth et al., 1979; Crompton et al., 1988; Petronilli et al., 
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1993). Chelation of matrix Ca2+ induces a rapid closure of PTP and divalent 
cations such as Mg2+, Mn2+, Ba2+ and Sr2+, instead of inducing PTP opening, 
can act as inhibitors of Ca2+ trigger sites (Bernardi et al., 1992). The 
relationship between MPT and cerebral ischemia inferred from the effects of 
CsA was nicely confirmed in CypD-knockout mice, by measuring the infarct 
size after cerebral ischemia/reperfusion injury induced by the occlusion of the 
middle cerebral artery (Schinzel et al., 2005). In this study, Schinzel and 
colleagues demonstrated that isolated, CypD-deficent mitochondria showed 
an increased capacity to retain calcium and were resistant to Ca2+-induced 
MPT in swelling experiments. When they induced ischemia/reperfusion, a 
dramatic decrease in infarct size (62%) was recorded in the brains of CypD 
deficient mice, suggesting an essential role for CypD in cell death in the 
brain. A correlation between gene dosage and the extent of injury was 
elegantly established, by recording a partial protection in heterozygous mice 
(37% of reduction in infarct size). These data proved that conditions required 
for the activation of PTP were present during ischemia/reperfusion, as 
suggested by earlier pharmacological studies (Shiga et al., 1992; Khaspekov 
et al., 1999; Matsumoto et al., 1999). Although the causal relationship 
between mitochondrial Ca2+ accumulation and PTP opening is well 
established, and despite the fact that MPT invariably leads to neuronal cell 
death, these relationships do not necessarily imply that matrix Ca2+ 
accumulation is directly responsible for the injuries related to cerebral 
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ischemia. The group of Lemasters, for example, has proposed that 
mitochondrial Ca2+ overload is a consequence, rather than a cause, of the 
bioenergetic failure that follows MPT onset. In this view, the mitochondrial 
Ca2+ elevation is only a signature of diseased mitochondria and is not 
involved in the induction of the MPT, which occurs after reperfusion (Kim et 
al., 2006). In this study of adult rat myocytes, ROS but not Ca2+ overload has 
been suggested to trigger pH- and MPT-dependent death after 
ischemia/reperfusion. Another important parameter to take into account is the 
timing of the PTP opening during ischemia/reperfusion. In the heart, there is 
a broad consensus that during ischemia the factors favoring PTP opening 
(increased matrix Ca2+ and depolarization) are balanced by PTP antagonists 
(intracellular acidosis, high levels of Mg2+ and ADP) that prevent PTP 
opening during ischemia (Di Lisa et al., 2011). Upon reperfusion, oxygen and 
substrate supplies are restored to the tissue, mitochondria re-energize, take 
up the Ca2+ that has accumulated in the cytosol during ischemia, and 
produce a burst in ROS. The combination of these factors provides ideal 
conditions for triggering PTP opening (Halestrap et al., 2010; Di Lisa et al., 
2011). Direct methods to asses PTP opening in intact hearts support the 
concept that PTP is more likely to open upon reperfusion (Griffiths et al., 
1995; Di Lisa et al., 2001). Whether the same sequence of events also 
occurs in ischemic brain is not known, and further studies are needed to 
determine the precise timing of the PTP opening during cerebral ischemia. 
24 
 
The recent identification of the proteins involved in mitochondrial Ca2+ uptake 
and release provides new opportunities to study the role of mitochondrial 
Ca2+ in neuronal death during cerebral ischemia. The role of calcium in MPT 
activation and cell death can now be directly tested by modulating the 
expression levels of mitochondrial transport proteins. Targeting the proteins 
that control the fluxes of Ca2+ should reveal whether altered mitochondrial 
Ca2+ handling is causally related to ischemic neuronal death, and can 
potentially increase the repertoire of therapeutic tools to treat ischemic brain 
diseases.  
It is not yet clear which sources of Ca2+ and which pathways are involved, 
however the defective cross-talk between intracellular stores is presumed in 
the etiopathogenesis of the injury (Bano D., 2007). 
The activation of intracellular second messengers Ca2+-related, the increase 
of reactive oxygen species, but also the same hypoxia, trigger the expression 
of many pro-inflammatory genes that induce synthesis of transcription factors 
such as the nuclear factor B (NFB) (O‘Neill L.A. et al., 1997) and the 
hypoxia inducible factor (HIF) (Ruscher, K. et al., 1998). Moreover, the 
inflammation mediators, such as platelet activating factor (PAF), tumoral 
necrosis factor (TNF-) and the interleukin-1, are produced by impaired 
neurons and glial cells. The activation of inflammatory process after stroke 
can induce many consequences and seems to be related to the apoptosis as 
well. Antibodies against adhesion molecules, as well as limits in the 
25 
 
development of inflammatory process, are able to reduce the number of cell 
dead in ischemic brain (Chopp, M. et al., 1996). 
 
In light of what has been said so far it is clear that the pathogenesis of 
ischemic injury is complex and depends on multifactorial events and that 
intracellular ionic homeostasis alterations, impaired mitochondrial function 
and the production of free radicals play a major role leading to neuronal 
death consequent to anoxic damage. 
This complexity of events explains the great discrepancy between the 
increasing number of cerebral ischemic accidents and the difficulty with 
which, unfortunately, are made studies in the development of effective 
treatments able to inhibit or slow the neuronal death following an ischemic 
episode. Hence the urgent need to identify new potential targets for the 
development of therapeutic strategies able to defend the ischemic brain. 
In this context, one approach that has received particular attention in recent 
years has been an important aspect of the ischemic process referred as 
ischemic tolerance. This phenomenon, also known as ischemic 
preconditioning, is a sub-lethal anoxic insult that increases the tissue 
tolerance to a subsequent and potentially lethal ischemia. The cerebral 
ischemic preconditioning is very important because give us the possibility to 
study the endogenous mechanisms activated in neurons to promote cell 
survival after this sublethal stimulus, and thus to develop new therapeutic 
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strategies more selective for the treatment of the ischemic  disease. The 
great interest in the cerebral ischemic preconditioning and in the tolerance 
evoked by itself, also comes from the similarity of this phenomenon with 
some clinical situations encountered in the human brain. Indeed, the 
tolerance evoked by brief ischemic episodes reminds the transient ischemic 
attacks (TIAs) that don‘t cause structural damage but appear to protect 
against a subsequent "stroke" (Weih et al., 1999a; Moncayo et al., 2000) and 
in clinical practice that precede a subsequent stroke. 
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ISCHEMIC PRECONDITIONING 
 
Ischemic preconditioning or ischemic tolerance of the brain, heart, and other 
organs refers to a natural adaptive process that can be induced by a variety 
of sublethal insults (e.g., transient hypoxia, spreading depression, oxidative 
stres, hyperthermia, heat shock), and which increases the tissue tolerance to 
a subsequent, potentially lethal ischemia. This adaptive cytoprotection is a 
fundamental capability of living cells, allowing them to survive exposure to 
potentially recurrent stressors. Clearly identified in the heart by Murry et al. in 
1986, preconditioning and subsequent ischemic tolerance were then 
demonstrated in the brain (Kitagawa et al., 1990), and attracted rapidly the 
interest of clinical and basic neuroscientists for several reasons. First, this 
biological process became widely recognized as a pertinent and effective 
experimental probe to understand how the brain protects itself against 
ischemia, thereby providing an innovative approach for the discovery of novel 
cerebroprotective strategies. Second, retrospective case-control studies 
showed a clinical correlate of the phenomenon discovered experimentally. 
Preconditioning induces two different time windows of tolerance. The first 
phase, named ―rapid preconditioning‖, occurs rapidly after the stimulus and is 
characterized by post-translational and metabolic modifications, ionic channel 
activation but is not dependent on the synthesis of new proteins; the second 
phase, named ―delayed preconditioning‖, corresponds to a robust state of 
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tolerance that is usually detectable 24 h after preconditioning induction, 
peaks at 3 days, fades after 7 days and requires the synthesis of new 
proteins. In the brain, conversely in the heart, the tolerance induced by 
ischemic preconditioning is generally of the delayed type (Kitagawa et al., 
1990; Liu et al., 1992; Nishi et al., 1993; Gidday et al., 1994; Goldberg et al., 
1998). 
The induction of ischemic tolerance is accompanied by substantial changes 
in gene expression, suggesting that preconditioning stimulates a fundamental 
genomic reprogramming of cells that confers cytoprotection and survival 
(Stenzel-Poore et al., 2007). The genomic response after ischemic 
preconditioning is a signature of the complex interplay of multiple signalling 
pathways. These highly specialized pathways in different cell types of the 
brain seem to refine the cellular and systemic response to combat the 
noxious stimulus. Hundreds of genes are either upregulated or 
downregulated in response to ischaemic preconditioning stimuli (Bernaudin 
et al., 2002; Stenzel-Poore et al., 2003; Tang et al., 2006). Changes in gene 
expression differ between harmful ischemia and ischemic preconditioning. 
Preconditioning seems to attenuate the response to ischemia (Stenzel-Poore 
et al., 2003) and the tolerance induced by it changes the expression of genes 
involved in the suppression of metabolic pathways, immune responses, ion-
channel activity, and blood coagulation (Stenzel-Poore et al., 2003). Gene 
expression is regulated by transcription factors but also depends on 
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epigenetic mechanisms such as DNA methylation and histone modification, 
which modify the chromatin structure that controls access of transcription 
factors to regulatory loci. Inhibitions of DNA methylation and increased 
histone acetylation have neuroprotective effects in experimental models of 
stroke (Endres et al., 2000). 
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EXPERIMENTAL MODELS OF ISCHEMIC PRECONDITIONING 
 
Starting from these assumptions many subsequent studies, both in vivo and 
in vitro, have confirmed the presence of the ischemic brain tolerance, and, in 
order to clarify the intracellular mechanisms underlying this phenomenon, 
several experimental models have been developed to reproduce in vitro and 
in vivo this condition. 
 
In vivo models 
A large number of studies in animal model of cerebral ischemia have shown 
that brief periods of non-lethal focal or global ischemia may have a protective 
effect against further episodes of brain ischemia. 
About three decades ago, was proposed a model in which Mongolian gerbils 
were subjected to bilateral carotid occlusion for 5 min followed by processing 
of their brains for light and electron microscopy. The authors reported that 
there occurred rapid ischemic changes in the CA4 region, with development 
of slower abnormalities in the CA2 area and even still slower changes in the 
CA1 region (Kirino et al., 1982). Using that model, others groups (Kitagawa 
et al., 1990) showed that exposure to 2 min of ischemia caused depletion of 
high-energy phosphate compounds and perturbation of protein synthesis 
without any evidence of neuronal death. In addition, they found that single 
episodes of 2-min ischemia were able to provide protection against cell death 
31 
 
caused by 5 min ischemic events performed 1 or 2 days after the 
pretreatment. Moreover, two 2-min ischemic pretreatments performed one 
day apart provided complete protection against cell death induced by 5 
minutes of ischemia (Kitagawa et al., 1990). The preconditioning with 2 min 
of ischemia prevented damage to the hippocampal CA1 area following 3 min 
of ischemia induced 3 days later (Kato et al., 1992). In addition, the 
pretreatment with unilateral occlusion of the middle cerebral artery (MCA) 
could induce ischemic tolerance in the hippocampal CA1 neurones of gerbils 
(Miyashita et al., 1994). Moreover, two minutes of preconditioning ischemia 
also protected gerbil hippocampal neurons against damage caused by a 3.5 
min ischemia performed 3 days later (Ohtsuki et al., 1996). Because previous 
investigators had focused their attention on younger animals and because 
most ischemic strokes occur in older individuals, other groups (Dowden et al., 
1999) used 18- to 20-month-old gerbils to test if they could observe 
preconditioning-induced protection in these animals. They found that two 
episodes of global ischemia, each lasting 1.5-minutes, separated by 24 hours 
protected animals who underwent a 5-minute occlusion of both carotid 
arteries 72 hours later. They also reported normal microtubule-associated 
protein-2 expression in the hippocampal CA1 region of preconditioned 
animals in contrast to the complete loss of microtubule-associated protein-2 
staining observed in ischemic animals.  
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The ischemic preconditioning was reproduced using rats to test if sub-lethal 
ischemia could protect against neuronal death caused by subsequent lethal 
ischemic insults (Liu et al., 1992). The forebrain ischemia for 3 min was able 
to protect against hippocampal CA1 neuronal damage caused by 6 and 8 min 
of ischemia but not against damage caused by 10 min of ischemia (Liu et al., 
1992). Other groups (Simon et al., 1993) also showed that two brief periods 
of global cerebral ischemia, separated by 24 h of normoxia, which did not 
cause significant cell death in the brain, were able to significantly reduce the 
size of an infarct caused by permanent MCA occlusion. It  was also reported 
that global ischemia can provide substantial protection against strokes 
caused by MCA occlusion in the rat brain (Matsushima et al., 1995). 
Moreover, in another very interesting study, the possibility that ischemic 
preconditioning applied only 30 min before a lethal insult could still offer 
protection against histological damage in the rat brain was assessed. In that 
study, the conditioning ischemic insult lasted 2 min. After only 30 min of 
reperfusion, the rats were subjected to 10-min of ischemia. This procedure 
caused a significant degrees of protection in the hippocampal CA1 subfield 
and in the cortex (Perez-Pinzon et al., 1997). 
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In vitro models 
Cell culture systems have also been used extensively to investigate the 
effects of preconditioning. The model of combined oxygen and glucose 
deprivation (OGD) that recapitulates the cascades of changes that occur 
during ischemia-induced injuries in the mammalian brain (Goldberg et al., 
1993; Martin et al., 1994) has been largely used to investigate the potential 
bases of preconditioning-induced neuroprotection. In that model, transient 
deprivation of rodent cortical cell cultures of both oxygen and glucose causes 
neuronal swelling, followed by severe neuronal degeneration over a period of 
several hours even when the cells were returned to normal media (Goldberg 
et al., 1993). Acute and delayed injuries were inhibited by combined removal 
of extracellular Ca2+ in conjunction with Na+ or Cl− substitution. The toxic 
effects of OGD appear to be mediated by excitotoxic damage because it 
causes a large increase in the levels of extracellular glutamate and because 
N-methyl-D-aspartate (NMDA) receptor antagonists provided protection 
against both the early and the late damage caused by OGD. Different groups 
used the OGD model to study the effects of preconditioning in vitro. They 
found that cellular damage was significantly reduced in cells pre-exposed to 
different short times (from 5 minutes to 90 minutes) of OGD with an interval 
of 24-48 hours before a second exposure to 3 hours of OGD. Interestingly, it 
was also reported that the preconditioned cultures were not protected against 
NMDA, kainate-, or glutamate-induced neuronal death (Grabb et al., 1999). 
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This is in contrast with a study in which it was reported that subjecting rat 
cortical cultures to a preconditioning OGD paradigm provided cross-tolerance 
to NMDA-induced cell death. It was also reported that NMDA receptor 
blockade during preconditioning by OGD eliminated tolerance (Tauskela et 
al., 2001). Another study comparing various preconditioning manipulations to 
OGD found that cycloheximide, heat stress, MK801 were as protective as 
OGD preconditioning in both acute and delayed models of ischemia-induced 
neuronal death (Meloni et al., 2002). Similar results have been reported using 
hippocampal slice cultures (Hassen et al., 2004), after combined deprivation 
of glucose and amino acids (Gaspar et al., 2006), and after exposure to 
neuronal cultures to various agents including anesthetic agents and 
diazoxide (Bickler et al., 2005; Kis et al., 2003), mild hypoxic insults 
(Khaspekov et al., 1998), as well as stimulation of adenosine receptors 
(Heurteaux et al., 1995). Interestingly, the OGD model was reproduced in 
organotypic cultures in which provided protection against cell death and the 
transient loss of evoked potential responses (Badaut et al., 2005). 
 
Other models of ischemic preconditioning 
In addition to ischemia preconditioning, there are other paradigms that have 
been shown to protect against ischemic injuries. These include spreading 
depression, hyperoxia and oxidative stress, prolonged hypoperfusion, and, 
as alluded to above, hyperthermia or heat shock. Therefore, one stressor can 
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promote ‗cross-tolerance‘ to another. The sheer variety of stimuli capable of 
inducing an ischemia-resistant phenotype in the brain indicates that the 
signalling pathways activated by these different triggers converge 
downstream on some common, fundamental mechanisms that ultimately 
account for the protection. Many exogenously delivered chemical 
preconditioning agents (for example, inflammatory cytokines, anaesthetics 
and metabolic inhibitors) can also induce ischemic tolerance, raising the 
hope that in the future it will be possible to pharmacologically activate these 
distal pathways in the human brain (Gidday, 2006). The efficacy of cross-
tolerance, relative to the classic ischemic preconditioning (i.e., brief, sublethal 
cerebral ischemia, with subsequent test ischemia that would damage the 
naıve brain) may be more modest, and it appears to vary with the nature and 
intensity of the first challenge. The window of ischemic tolerance may be also 
shifted or different; for example, the ―tolerizing‖ effect or LPS needed more 
time to be manifest, starting at 48 h after LPS injection and reaching full 
potential at 72 h as described in the study of Tasaki et al. (Tasaki et al., 
1997). Cross-tolerance is an important feature, but potentially misleading by 
suggesting that different preconditioning stimuli result ultimately in similar 
mechanisms of tolerance. That may be only partially true, and dependent on 
the nature of the stimuli considered. Comparison of the genomic profiles of 
brain responses to ischemia from mice preconditioned with either brief 
ischemia or low-dose LPS revealed that a substantial subset of the 
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differentially-expressed genes were unique to each preconditioning stimulus 
(Stenzel-Poore et al., 2007). This suggests that the nature of the 
preconditioning stimulus may determine a specific neuroprotective 
phenotype. When a specific variable (gene expression, level of a specific 
protein, etc.) is found to be altered in animals subjected to both 
preconditioning stimulus and test insult, this change may be causally related 
to the mechanism of protection, and this interpretation is often favored by 
authors. However, as the fundamental nature of preconditioning is to protect 
the brain against a subsequent insult, an alternative and valid interpretation 
may be that the identified change simply reflects, or is an epiphenomenon of, 
the reduced damage. 
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INTRACELLULAR MECHANISMS ACTIVATED BY ISCHEMIC 
PRECONDITIONING 
 
Recently, three phases temporally consecutives of the preconditioning 
phenomenon have been identified: induction, transduction, and tolerance. 
To induce tolerance, the preconditioning stimulus must be recognized by 
molecular sensors as a sign of something potentially much more severe to 
come. So far, numerous types of sensor have been identified, including 
neurotransmitter, neuromodulator, cytokine and toll-like receptors (Kariko et 
al., 2004) as well as ion channels and redox-sensitive enzymes. In turn, 
these sensors activate transduction pathways that initiate the adaptive 
response. Although dependent in part on the nature of the preconditioning 
stimulus, members of these transduction pathways for which there is strong 
general support include mitogen-activated protein kinases (MAPKs) and their 
phosphorylated Ras, Raf, MEK and ERK subfamilies (Dawson et al., 2000; 
Gonzalez-Zulueta et al., 2000; Jones et al., 2004), mitochondrial ATP-
sensitive K+ (KATP) channels (Heurteaux et al., 1995; Yoshida et al., 2004) 
Akt (also known as protein kinase B) (Yano et al., 2001; Wick et al., 2001; 
Hashiguchi et al., 2004) and the protein kinase C-ε isoform (Raval et al., 
2003). The possibility that the nitric oxide-based adaptive response to 
hypoxia in Drosophila (Wingrove et al., 1999) is evolutionarily conserved 
suggests that this multifunctional modulator might be a logical choice as an 
autocrine and paracrine mediator of preconditioning stress. Indeed, 
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pharmacological and genetic evidence supporting the involvement of nitric 
oxide in the transduction process is continuing to mount. Given the redox 
sensitivity of many kinases and transcription factors, reactive oxygen species 
might also serve as transducers (Puisieux et al., 2004; Zhang et al., 2004; 
Ravati et al., 2001). Adenosine, another prototypical paracrine mediator and 
‗retaliatory metabolite‘, the production of which is linked to ATP degradation, 
seems integral to tolerance induction in some models (Heurteaux et al., 
1995; Yoshida et al., 2004; Plamondon et al., 1999; Nakamura et al., 2002). 
Finally, caspases might be essential induction catalysts, given that cyclic 
AMP responsive element-binding protein (CREB), the p50 and p65 subunits 
of nuclear factor-κB (NF-κB), and protein kinase C and other kinases are 
caspase substrates (McLaughlin et al., 2003; Algeciras-Schimnich et al., 
2002). Notably, some of the aforementioned molecular transducers and 
signalling intermediates also serve as post-ischaemic effectors of the 
ischaemia-tolerant phenotype (Dirnagl et al., 2003). 
 
Role of nitric oxide 
Nitric oxide (NO) is synthesized from L-arginine and oxygen by the 
oxidoreductase nitric oxide synthase, an enzyme present in three isoforms: 
neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible or 
‗immunological‘ NOS (iNOS) (Alderton et al. 2001). NO exerts its biological 
effects by reacting with oxygen, superoxide, or transitional metal centres 
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(Gross & Wolin, 1995; Pacher et al. 2007). The cytoprotective effects of NO 
typically occur through direct post-translational modification of proteins (S-
nitrosylation), through activation of the cGMP second messenger system and 
through reaction with superoxide to form peroxynitrite. S-Nitrosylation, 
produced by the direct reaction of NO with cysteine thiol groups, has been 
linked to neuroprotection through inhibition of NMDA receceptor activity (Lei 
et al. 1992; Lipton et al. 1993; Kim et al. 1999). In addition, S-nitrosylation 
may confer neuroprotection by inhibition of apoptosis, particularly through 
inactivation of caspases, proteases that degrade key intracellular proteins 
(Melino et al. 1997; Budihardjo et al. 1999; Zhou et al. 2005). S-Nitrosylation 
also leads to activation of the mitogen-activated protein kinase/extracellular-
signal-regulated kinase (MAPK/ERK) pathway (Yun et al. 1998), which 
triggers the expression of prosurvival genes in cortical neurons. S-
Nitrosylation can also play a role in gene expression through modification of 
transcription factors involved in neuronal survival, such as CREB (cyclic 
adenosine monophosphate response element binding; Lonze & Ginty, 2002). 
Recently, a study in cortical neurons found that the brain-derived 
neurotrophic factor (BDNF), well known for its role in cell survival, induced 
CREB binding to target DNA (Riccio et al. 2006). These effects of NO on 
CREB-DNA binding are mediated by S-nitrosylation of histone deacetylase 2 
(HDAC2) (Riccio et al. 2006). In addition, S-nitrosylation of the p50 subunit 
negatively regulates the pro-inflammatory transcription factor NF-κB (nuclear 
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factor κ light chain enhancer of activated B cells), possibly contributing to an 
anti-inflammatory environment (Colasanti & Persichini, 2000). A main 
biological target of NO is the haem-containing enzymesoluble guanylyl 
cyclase (sGC), which catalyses the conversion of GTP to cGMP. Numerous 
studies suggest that NO-dependent elevations in cGMP and consequent 
activation of protein kinase G (PKG) inhibit cell death and activate prosurvival 
pathways. A role for NO in the expression of specific neuroplasticity-
associated proteins, including BDNF, was recently demonstrated in cortical 
neurons and in the whisker barrel cortex, an effect that involves cGMP/PKG 
and ERK signalling (Gallo & Iadecola, 2011). Similarly, cGMP improves 
synaptic function and CREB activation in a mouse model of Alzheimer‘s 
disease (Puzzo et al. 2009). A glimpse into the cellular mechanisms of NO 
protection downstream of PKG is provided by studies in cardiomyocytes. 
Following ischaemia–reperfusion, NO-dependent PKG activity leads to 
activation of protein kinase Cε, which phosphorylates mitochondrial ATP-
sensitive K+ (mitoKATP) channels (Costa & Garlid, 2008). The subsequent 
opening of the channels results in cytoprotection by inhibiting the 
mitochondrial transition pore (Costa & Garlid, 2008). Opening of mitoKATP 
channels is also associated with neuroprotection through mechanisms 
related to stabilization of mitochondrial function and prevention of apoptosis 
(Liu et al. 2002; Mayanagi et al. 2006). NO rapidly reacts with superoxide to 
form peroxynitrite (Beckman et al. 1990). Besides its well-established its toxic 
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potential at high concentrations (Calabrese et al. 2009), at low concentrations 
peroxynitrite can act as a signalling molecule (Liaudet et al. 2009). For 
instance, in the vasculature, peroxynitrite is able to induce vascular relaxation 
and inhibition of platelet aggregation (Liu et al. 1994; Moro et al. 1994). 
Peroxynitrite protects cardiomyocytes from ischaemia–reperfusion injury 
(Lefer et al. 1997), an effect associated with inhibition of leukocyte adhesion 
to endothelial cells. In addition, peroxynitrite leads to redox modulation of 
proteins within signalling cascades that mediate neuroprotection (Liaudet et 
al. 2009). For example, peroxynitrite activates ERK and Akt signalling in 
different cells promoting their survival (Jope et al. 2000; Pesse et al. 2005; Li 
et al. 2006). These observations suggest that NO has powerful protective 
effects that involve not only pro-survival signalling pathways, but also blood 
flow and vascular inflammatory events that play a prominent role in 
ischaemic brain injury. These aspects of NO biology are critical for 
understanding the protective effect that NO exerts in the context of ischaemic 
preconditioning. Indeed, NO has been implicated both in early and late 
preconditioning in the newborn as well in the adult brain. NO derived from 
eNOS and nNOS is essential for induction of tolerance in models of early 
preconditioning. For example, the lesion produced by neocortical injection of 
the glutamate receptor agonist NMDA was markedly reduced 1 h after 
administration of the pro-inflammatory mediator LPS in mice (Orio et al. 
2007). The effect was not abolished by the protein synthesis inhibitor 
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anisomycin, attesting to the fact that the protection did not require new 
protein synthesis, a hallmark of early preconditioning. The protection 
conferred by LPS was abolished by inhibitors of nNOS, and could be 
reconstituted by neocortical injection of a NO donor. Furthermore, the 
tolerance was not observed in nNOS or eNOS null mice, but was preserved 
in iNOS null mice and in mice treated with the iNOS inhibitor aminoguanidine 
(AG) (Orio et al. 2007). In agreement with LPS preconditioning in NMDA 
lesions, the early tolerance to focal ischaemic injury produced by a transient 
episode of focal cerebral ischaemia was not observed in eNOS or nNOS null 
mice (Atochin et al. 2003), suggesting that eNOS and nNOS-derived NO is 
also involved in other preconditioning and injury modalities. These 
observations implicate eNOS and nNOS, but not iNOS, as sources of NO. 
There is evidence that the mechanisms by which NO induces early tolerance 
involve the second messenger cGMP. The mechanisms by which cGMP 
leads to tissue protection may involve PKG and mitoKATP channels. These 
observations, collectively, indicate that NO is critical for the establishment of 
ischaemic tolerance induced by transient ischaemia or by the 
proinflammatory mediator LPS, an effect involving activation of sGC and 
cGMP Production. Mounting evidence suggests that NO is also involved in 
delayed preconditioning. In hypoxic preconditioning in a neonatal rat model of 
ischaemic–hypoxic damage, the protection is abolished by the non-selective 
NOS inhibitor nitro-L-arginine, but not by the nNOS inhibitor 7-nitroindazole 
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or the iNOS inhibitor AG implicating eNOS as the source of NO. Similar 
results were obtained in another model of preconditioning in neonatal rats 
(Lin et al. 2010). With some exceptions (Hashiguchi et al. 2004;Vellimana et 
al. 2011), the majority of studies on the role of NO in delayed preconditioning 
in the adult have indicated that the source of NO is iNOS. Studies in adult 
mice have revealed a key role of iNOS in the preconditioning produced by 
LPS or transient forebrain ischaemia. iNOS null mice do not develop 
tolerance to focal ischaemia or NMDA lesions after treatment with LPS or 
transient forebrain ischaemia (Cho et al. 2005; Kawano et al. 2007; Kunz et 
al. 2007). Similarly, AG prevents the development of tolerance in these 
models. The preconditioning is associated with an increase in mitochondrial 
resistance to calcium-mediated depolarization (Cho et al. 2005), supporting 
the involvement of mitochondria also in the mechanisms of delayed 
tolerance. There is increasing evidence that preconditioning stimuli, in 
addition to changes in gene expression and mitochondrial function, also 
improve cerebrovascular function (Gidday, 2006). Therefore, the 
mechanisms of ischaemic tolerance may also include vascular effects that 
lead to an improvement of cerebral perfusion and blood–brain barrier 
function. 
Moreover, is well known that NO generated by nNOS activates the G-protein 
Ras (Lander et al., 1995; Yun et al., 1998; Kolch et al., 2000). Ras, in turns also 
stimulates the PI3 kinase/Akt pathway. This signaling pathway is now largely 
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recognized as one of the most relevant pathways in regulating neuronal 
survival (Song et al., 2005). Indeed, it has various functions: 1) it regulates 
glucose metabolism; 2) it inactivates the mitochondrial death pathway (i.e., 
BAD and caspase 9) and FOXO pathway; 3) it activates CREB 
phosphorylation, which regulates the expression of genes critical for survival, 
such as those encoding for cytokines and brain derived neurotrophic factor; 
and 4) it activates the antiapoptotic factor nuclear factor-B through the 
activation of IkB kinase complex (Fukunaga and Kawano, 2003). In addition, 
Akt regulates Ca2+ homeostasis through the potentiation of L-type voltage-
gated calcium channels (Blair et al., 1999), sarco(endo)plasmatic Ca2+ 
ATPase (Kim et al., 2003), and intracellular ligand-gated ion channels (Barac 
et al., 2005), thus enhancing neuronal survival. Moreover, it has been 
demonstrated that the overexpression of constitutively active Akt1, the most 
highly diffused and expressed isoform in the brain (Hanada et al., 2004; Hui 
et al., 2005), induces an up-regulation of NCX1 and NCX3. Indeed, the 
overexpression of NCX1 and NCX3 isoforms induced by this serine-threonine 
kinase was only partially responsible for the 80% reduction of hypoxia 
induced cell death by Akt1-positive mutants, because siRNA-NCX1 and 
siRNA-NCX3 reduced this neuroprotective effect to values of 26 and 28%, 
respectively. This result suggested that Akt1, besides activating several 
neuroprotective pathways, produces an overexpression of NCX1 and NCX3 
that may contribute to the reduction of hypoxia-induced cell death through an 
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improvement of intracellular Ca2+ and Na+ dysregulation. Together, these 
findings indicate that NCX1 and NCX3 constitute novel and additional targets 
of Akt neuroprotective action. 
Overall, these downstream effector mechanisms of Akt1 result in a program 
of cell survival. 
 
Role of inflammatory cytokines 
Inflammatory cytokines are known to have an important role in acute stroke. 
Cytokines such as interleukin-1 (IL-1), and TNF-α are important mediators of 
the inflammatory reactions seen in cerebral ischemia (Kariko et al., 2004). 
TNF-α is one of the pro-inflammatory cytokines and is expressed in the 
ischemic brain. The effects of pretreatment with TNF administered 
intracisternally in mice that were subjected to MCAO 48 h later were studied 
(Nawashiro et al., 1997). A significant reduction in infarct size was noted in 
mice pretreated with TNF at the dose of 0.5 microgram/mouse. 
Immunohistochemical analysis of brains subjected to 24 h of MCAO revealed 
a significant decrease in CD11b immunoreactivity after TNF pretreatment 
compared with the MCAO control. Therefore, TNF induces significant 
protection against ischemic brain injury and is likely to be involved in the 
signaling pathways that regulate ischemic tolerance. Liu et al (Liu et al., 
2000) demonstrated that preconditioning of rat cortical neurons with mild 
hypoxia protected them from hypoxia and oxygen and glucose deprivation 
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(OGD) injury 24 h later (50% protection). Interestingly, TNF-α pretreatment 
could be substituted for hypoxic preconditioning (HP). HP was attenuated by 
TNF-α-neutralizing antibody. The role of IL-1 in the induction of tolerance to 
global ischemia in Mongolian gerbils was also demonstrated (Ohtsuki et al., 
1996). Arterial IL-1α and IL-1β became elevated between 1 and 3 days after 
a 2-min ischemic exposure. Recombinant human IL-1 receptor antagonist 
(IL-1ra) blocked ischemic tolerance induction by 2-min preconditioning 
ischemia. The possible mechanisms of IL-1 action include release of 
arachidonic acid, enhancement of NMDA activation and stimulation of nitric 
oxide synthase (Huang et al., 2006). 
 
Role of heat shock proteins (HSPs) 
Although most protein synthesis is inhibited after cerebral ischemia, the 
remaining active protein synthesis may have an important role in maintaining 
cell viability. HSPs are molecular chaperones and among the proteins 
synthesized during ischemia. HSPs are expressed both constitutively 
(cognate proteins) and under stressful conditions (as inducible forms). In 
addition to heat shock, a variety of stressful situations including 
environmental (ultraviolet radiation or heavy metals), pathological (infections 
or malignancies), or physiological (growth factors or cell differentiation) 
stimuli induce a marked increase in HSPs synthesis, known as the stress 
response (Tsan et al., 2004). Inducible HSPs are thought to assist the 
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maintenance of cellular integrity and viability by preventing protein 
denaturation and improper polypeptide aggregation during exposure to 
physiochemical insults (Ravati et al., 2001). 
HSP70 is the most abundant HSP found in cells. It is expressed constitutively 
and is only mildly inducible. Many researchers have shown the extensive 
links between HSP70 overexpression and tolerance in ischemic brain injury. 
Some of them have reported an increase in HSP70 expression in an in vivo 
model of preconditioning (McLaughlin et al., 2003). Furthermore, HSP70 
messenger RNA (mRNA) was compared in the cases of a 15-min ischemia 2 
days after sham treatment and a 15-min ischemia 2 days after 10-min 
preconditioning (Sakurai et al., 1998). The authors reported that HSP70 
mRNA in the motor neurons was strong at 8 h after preconditioning with 10-
min ischemia, mild at 1 or 2 days, and not observed at 7 days after 
preconditioning. Others reported that thermal preconditioning with 44oC body 
temperature protected rat cerebellar granule neurons by modulating HSP70 
expression. HSP70 mRNA was detected after thermal preconditioning at 30, 
60, and 90 min and increased gradually with time, whereas HSP70 antisense 
oligodeoxynucleotides inhibited the protective effects of thermal 
preconditioning against apoptosis (Chen et al., 2004). All these results 
implicate that HSP70 is an important player in the preconditioning process. 
The underlying mechanisms of ischemic brain tolerance HSP70-mediated 
are not only related to its important functions in protein refolding and 
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transport. Emerging evidence suggests that the HSP70 family is also capable 
of binding and sequestering activated caspases, such as Apaf and AIF 
(Yenari et al., 1999). Overexpression of HSP70 inhibits the activation of NF-
κB, which is persistently activated during ischemia and appears to promote 
apoptotic cell death. On the contrary, the deletion of the HSP70 gene notably 
increases cytochrome c release into the cytoplasm and subsequent caspase- 
3 activation, thereby exacerbating apoptosis and increasing infarction volume 
after focal cerebral ischemia (Lee et al., 2004). Furthermore, HSP70 
expression is regulated by transcription factors, the activity of which is 
increased by ERK phosphorylation (Minet et al., 2000), a process which has 
been implicated in preconditioning. 
 
Role of the anti-apoptotic protein Bcl-2 
The protein Bcl-2 is an anti-apoptotic protein that resides in the outer 
mitochondrial membranes and the membranes of the endoplasmic reticulum. 
Overexpression of Bcl-2 is known to block the release of cytochrome c, which 
contributes to a signaling pathway leading to apoptosis. Indeed, two minutes 
of bilateral carotid artery occlusion in gerbils produced an increase in Bcl-2 at 
30 h and peaked at 96 h, suggesting that the expression of Bcl-2 is involved 
in ischemic preconditioning (Kato et al., 1991). In addition, 20 min of transient 
focal ischemia, representing a sub-lethal insult, produced ischemic tolerance 
(attenuated infarction volume) (Shimizu et al., 2001). The results of Western 
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blot analysis from tolerant caudate-putamen demonstrated an increase in 
Bcl-2 expression 3–7 days after preconditioning. Immunocytochemical 
examination also found that Bcl-2 was expressed in cells with both neuronal 
and non-neuronal morphology in striatum. Bcl-2 antisense 
oligodeoxynucleotides (ODNs) treatment reduced expression of Bcl-2 in the 
striatum and blocked the induction of tolerance by preconditioning ischemia. 
Therefore, Bcl-2 appears to be a major determinant in this model of induced 
tolerance to focal ischemia. The transcription factors driving the induction of 
Bcl-2 during tolerance include CREB, indeed it has been described a cAMP-
responsive element in Bcl2 promoter. As mentioned above, CREB is 
regulated by NMDA receptor activation, and phosphorylated robustly in the 
penumbral region of the preconditioned rats (Nakajima et al., 2002). 
Moreover, multiple protein kinases can activate transcription via the CRE, by 
phosphorylation of CREB, further implicating that the interrelation of these 
different molecular regulatory pathways could be involved in ischemic 
preconditioning. 
 
Role of adenosine A1 receptors and ATP-sensitive K
+ channels 
In 1995, was demonstrated the essential role of adenosine, adenosine A1 
receptors, and ATP-sensitive K+ channels in ischemic brain preconditioning. 
Adenosine is an endogenous neuroprotectant that can inhibit the release of 
excitatory amino acids. When ischemia occurs, adenosine can increase 
conspicuously. Adenosine inhibits synaptic transmission, decreases K+-
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stimulated glutamate release, and inhibits presynaptic calcium fluxes via 
adenosine A1 receptors. The response to calcium influx is also important for 
the development of protection against ischemia, because calcium influx has 
been linked to the production of reactive oxygen species and the initiation of 
a number of signaling cascades leading to cell damage (Kristian et al., 1998). 
Many reports have shown that preconditioning-induced neuroprotection is 
dependent on adenosine A1 receptors. In rats, ischemic preconditioning 
increased adenosine A1 receptor immunoreactivity in the hippocampal CA1 
region at days 1, 3, and 7 after preconditioning induction, within the window 
of ischemic tolerance (Zhou et al., 2004). Some unspecific and specific 
adenosine A1 receptor antagonists abolished the ischemic tolerance. 
Moreover, was demonstrated that the tolerance isoflurane-induced against 
focal cerebral ischemia model was attenuated by adenosine A1 receptor 
antagonists in a rat middle cerebral artery occlusion (MCAO) (Liu et al., 
2006). Activation of the ATP-sensitive potassium channels (K+ ATP 
channels) also has a role in ischemic brain preconditioning. Blockade of the 
K+ ATP channels abolished preconditioning and the protection afforded by 
adenosine and R-PIA (an adenosine A1 receptor agonist). By contrast, a K+ 
ATP channel opener (RP-52891, aprikalim) induced ischemic tolerance. 
Meanwhile, recent evidence showed that transient infusion of the K+ ATP 
channel antagonist sulfonylurea tolbutamide prior to ischemia could block 
preconditioning induced protection after forebrain ischemia, whereas 
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pinacidil, a K+ ATP channel agonist, can emulate this phenomenon in 
hippocampal slices (Pérez-Pinzón et al., 1999). Although the precise K+ ATP 
channels involved in the tolerance remain undefined, two K+ ATP channels 
have been described recently. One of these channels resides in the 
mitochondrial inner membranes; the other resides in the plasma membranes. 
The mitochondrial K+ ATP (mK+ATP) has been suggested to be the key 
channel involved in ischemic preconditioning, because the mK+ ATP blocker 
5-hydorxydecanoate (5-HD) prevented BIP-induced neuroprotection. It has 
been hypothesized that opening the mK+ ATP channels may depolarize 
mitochondrial membrane potential and promote an increase in the electron 
transport chain rate and thus increase ATP production (Schultz et al., 1999). 
 
Role of opioid receptors 
There are three types of opioid receptor: δ, κ, μ opioid receptors. The 
activation of opioid receptors is neuroprotective when the body encounters 
ischemia, hypoxia and cold. Zhang and collaborators showed that the δ 
opioid receptors were involved in hypoxia preconditioning in cultured rat 
cortical neurons (Zhang et al., 2001). They observed that δ opioid receptor 
activation protected cortical neurons from hypoxia injury, whereas the δ 
opioid receptor antagonist naloxone blocked such protection. In addition, 
another group found that morphine (an agonist for δ, κ, μ opioid receptors) 
and Tan-67 (a selective δ receptor agonist) induced a delayed 
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preconditioning effect both in vivo and in vitro. The morphine preconditioning-
induced neuroprotection was inhibited by β-funaltrexamine, a μ-opioid 
receptor antagonist, but not by 7-benzylidenenaltrexone, a δ-receptor 
antagonist, or norbinaltorphimine, a κ-receptor antagonist. The Tan-67 
preconditioning-induced neuroprotection was inhibited by 7-
benzylidenenaltrexone. These results suggest that the delayed phase of 
morphine preconditioning may involve μ opioid receptors and δ opioid 
receptors. Morphine and Tan-67 may activate a shared intracellular signalling 
pathway to induce the delayed preconditioning effects in the brain (Zhao et 
al., 2006). 
 
Role of the ubiquitin-proteasome pathway 
There are two protein degradation systems in mammalian cells, the 
autophagy/lysosomal pathway and the ubiquitinproteasomal pathway. The 
ubiquitin-proteasomal pathway has been studied in cerebral ischemia and 
ischemic preconditioning. In rat forebrain ischemia models, transient cerebral 
ischemia followed by reperfusion leads to delayed selective neuronal death in 
hippocampal CA1 pyramidal neurons. Under electron microscopy (EM), 
visible protein aggregates progressively accumulate in some CA1 neurons 
and accumulation of the aggregates seem to occur primarily in neurons 
destined to undergo delayed neuronal death after brain ischemia. 
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Further evidence (Yoneda et al., 2004; De Gracia et al., 2007) showed that 
the endoplasmic reticulum (ER), mitochondria and cytoplasm all respond to 
the accumulation of unfolded proteins by compartment-specific signaling 
pathways to participate in neuronal injury, whereas ubiquintin-proteasome as 
well as beneficial chaperones function to prevent protein aggregation and 
assist in protein folding (Ghaemmaghami et al., 2003; Hebert et al., 2007). 
Furthermore, by utilizing a rat transient cerebral ischemic preconditioning 
model, was demonstrated that ischemic preconditioning significantly reduced 
protein aggregation in CA1 neurons after ischemia. Biochemical analyses 
revealed that ischemic preconditioning decreased accumulation of ubiquitin-
conjugated proteins (ubi-proteins) and reduced free ubiquitin depletion after 
brain ischemia. Ischemic preconditioning also reduced redistribution of heat 
shock cognate protein 70 and Hdj1 (HSP40) from cytosolic fraction to protein 
aggregate-containing fraction after brain ischemia (Liu et al., 2005). Indeed, 
the proteasome comprises multiple protein subunits and degrades cytosolic 
proteins as well as misfolded proteins that fail to pass protein quality control 
in the ER (Wu et al., 2006). Misfolded proteins in the ER are recognized by 
ER-specific E3 ligases that mediate polyubiquitination of the misfolded 
protein on the cytosolic side of the ER and are subsequently degraded by the 
proteasome (Chen et al., 2008). Proteasome degradation of ubi-proteins is 
strictly ATP-dependent. Ubi-proteins serve as signals to activate heat shock 
transcription factors to induce expression of molecular chaperones (Voellmy 
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et al., 2004), which then shield hydrophobic surfaces of proteins in non-native 
states, thereby blocking their aggregation. Major cellular chaperones are 
ATPases and assist protein folding through numerous cycles of binding and 
release of unfolded protein substrates by hydrolysis of ATP. Therefore, 
ubiquitin–proteasome and molecular chaperons may be concerned with the 
neuroprotection of ischemic preconditioning and may together prevent 
protein aggregation in lethal ischemia. 
 
Role of autophagy/lysosomal pathway 
Recently, the roles of autophagy and the lysosomal pathway in cerebral 
ischemia have attracted intensive attention. Studies have reported the 
activation of autophagy following ischemic insults, but the contribution of 
autophagy to neuronal death/ survival is still under debate (Adhami et al., 
2006; Carloni et al., 2008; Koike et al., 2008; Rami et al., 2008; Balduini et 
al., 2009). In an earlier study, we found profound activation of autophagy and 
lysosomes after permanent middle cerebral artery occlusion (pMCAO) and 
an autophagic mechanism may contribute to ischemic neuronal injury (Wen 
et al., 2008). However, autophagy is a double-edged sword (Shintani et al., 
2004). Although massive autophagy is associated with cell death through 
excessive self-digestion and degradation of cellular constitutions, activation 
of autophagy can also protect the neurons by degrading unfolded proteins 
and damaged organelles. A study carried out in primary cultured 
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cardiomyocytes (Dosenko et al., 2006) showed that inhibition of autophagy 
with 3-methyladenine (3-MA, an autophagy inhibitor) during anoxia-
reoxygenation caused an increase in the number of necrotic cells and a 
decrease of the living cell population. Thus, the process of autophagy during 
anoxia-reoxygenation was proposed to provide some protective effects. In 
addition, a recent in vitro study in PC12 cells also showed that autophagy 
was associated with neuroprotective effects induced by IPC (Park et al., 
2009). Inhibition of autophagy, especially during reperfusion or lethal oxygen-
glucose deprivation periods, ameliorated the neuroprotective effects of IPC, 
and also attenuated HSP70 upregulation induced by IPC. Furthermore, our 
recent observations showed that autophagy was also induced in a rat 
ischemic preconditioning model. Pretreatment with 3-MA before the onset of 
ischemic preconditioning completely suppressed the neuroprotective effects 
of preconditioning. These results strongly supported the hypothesis that 
induction of autophagy in ischemic preconditioning may play a part in 
protecting against the sequential lethal cerebral ischemia (Sheng et al, 
manuscript submitted). 
 
Role of hypoxia inducible factor-1 (HIF-1) 
Activation of hypoxia-inducible factor-1 (HIF-1) has been proposed as a 
crucial event in the regulation of hypoxia-inducible gene expression in 
mammalian cells (Semenza, 2000). HIF-1 is a member of the basic helix-
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loop-helix family of transcription factors and requires the dimerization of HIF-
1 and HIF-1 subunits for its activity (Wang and Semenza, 1995). Hypoxia-
inducible factor-1 heterodimer binds to a specific DNA consensus sequence 
in the enhancer and promoter regions of many hypoxiainducible genes (Ebert 
et al., 1996; Semenza et al., 1994, 1996). Under normoxic conditions, HIF-1 
protein is negatively regulated by ubiquitination and proteasomal degradation 
(Huang et al., 1998; Kallio et al., 1999) such that constitutive levels of HIF-1 
protein are generally low or undetectable (Wiener et al., 1996; Bergeron et 
al., 1999b, 2000). During hypoxia, HIF-1 expression and concomitant HIF-1 
DNA binding activity are markedly increased in several cell lines (Wang and 
Semenza, 1995; Wang et al., 1995; Jiang et al., 1996a) and primary neuronal 
cultures (Ruscher et al., 1998). In the brain, increased HIF-1 expression 
has been observed in rats exposed to systemic hypoxia (Wiener et al., 1996; 
Bergeron et al., 2000) or subjected to global (Jin et al., 2000) and focal 
ischemia (Bergeron et al., 1999b; Marti et al., 2000). Interestingly, in vitro 
exposure to the divalent metal cobalt chloride (CoCl2) or the iron chelator 
desferrioxamine during normoxic conditions triggers transcriptional changes 
that mimic a hypoxic response that is characterized by increased HIF-1 and 
HIF-1 expression, up-regulation of HIF-1 binding activity, and consequent 
HIF-1 target gene expression (Ebert et al., 1996; Semenza et al., 1994, 1996; 
Zaman et al., 1999). The hypoxia-mimetic effect of these compounds may 
involve the interaction with a ferroprotein oxygen sensor. Recent evidence 
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has shown that HIF-1 and HIF-1 mRNA and protein are induced after 
preconditioning with hypoxia or CoCl2 in neonatal rats, suggesting that HIF-
1–regulated gene expression may be involved in the hypoxia-induced 
tolerance to ischemic injury in immature brain (Bergeron et al., 2000). 
Recently, we demonstrated that the gene coding for the ubiquitous Na+/Ca2+ 
exchanger NCX1 protein can be included in the family of genes activated by 
the transcription factor HIF-1. This regulation assumes particular relevance in 
light of the recently emerged role of HIF-1 and NCX1 in several 
pathophysiological aspects of cerebral ischemia. In fact, neuron specific 
knocking-out of HIF-1α exacerbates brain damage after tMCAO, suggesting 
its neuroprotective action (Baranova et al., 2007). Similarly, NCX1 knocking-
down by oligodeoxynucleotide antisense strategy increases infarct damage 
after permanent middle cerebral artery occlusion (Pignataro et al., 2004). 
Interestingly, ncx1 transcript levels have been demonstrated to be up-
regulated in regions surrounding the ischemic core (Boscia et al., 2006). 
Therefore, HIF-1-dependent up-regulation of ncx1 expression provides an 
additional mechanism involved in the pro-survival role attributed to HIF-1. 
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Cellular ionic homeostasis and energy metabolism 
As ischemic preconditioning activates intracellular biological responses prior 
to a potential lethal insult, it is expected that an increase of energy 
metabolism or a latency in anoxic depolarization after the onset of ischemic 
insult might represent the mechanisms by which organs strengthen their 
tolerance when exposed to a sublethal insult. In this regard, several 
experiments have been performed, both in vivo and in vitro, in order to 
demonstrate that a reduction in energy demand and in the activity of ion 
channels represent determinant factors for ischemic tolerance (Stenzel-
Poore et al., 2003). In fact, impairment in voltage-gated potassium channels 
has been observed in cortical neurons exposed to brief non injurious oxygen 
and glucose deprivation. Similarly, in vivo experiments demonstrated that 
ischemic preconditioning prevented the inhibition of Na+⁄K+-ATPase activity 
after brain ischemia in hippocampal and cortical neurons of rats exposed to 
global forebrain ischemia (De Sonza et al., 2000). In the last years, it has 
been shown that some integral plasma-membrane proteins, involved in the 
control of Ca2+ and Na+ ion influx or efflux and, therefore, responsible for 
maintaining the homeostasis of these two cations, might function as crucial 
players in the brain ischemic process (Pignataro et al., 2004). These 
proteins, by regulating Na+ and Ca2+ homeostasis may represent more 
suitable molecular targets for therapeutic intervention. Indeed, during 
ischemic preconditioning, the results of in vivo experiments in gerbils showed 
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an increase in Ca2+-ATPase activity and an enhancement in mitochondrial 
calcium sequestration in CA1 hippocampal neurons after preconditioning 
(Ohta et al., 1996). In line with this result, intracellular calcium imaging 
performed in hippocampal neurons of preconditioned gerbils showed that the 
increase in [Ca2+]i occurring after anoxic and aglycemic episodes was 
markedly inhibited in the ischemic tolerant animals (Shimazaki et al., 1998). 
The molecular mechanisms underlying this effect are still under investigation. 
A possible explanation could be increased expression of the Ca2+-ATPase 
isoform 1 [plasma membrane calcium ATPase 1 (PMCA-1)] as recently 
demonstrated by Kato et al. (Kato et al., 2005). Also, mitochondria co-operate 
in the regulation of intracellular Ca2+ homeostasis, both in physiological and 
in pathological conditions. Although mitochondria have a high capacity for 
Ca2+ sequestration, excessive amounts of Ca2+, as it occurs during ischemia, 
impair mitochondrial function. This induces a massive uncoupling of oxidative 
phosphorylation and reduction of mitochondrial membrane potential with 
consequent mitochondrial permeability transitional pore (MPTP) opening and 
reversal of the action of ATPase, which in turn hydrolyses, rather than 
synthesizes, ATP. As a consequence of ATP depletion and increased 
permeability of the inner mitochondrial membrane, cell death occurs. Studies 
performed both in the heart and in the brain suggested that the inhibition of 
MPTP opening and its signalling cascade represent crucial events 
responsible for cytoprotection observed in ischemic preconditioning 
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(Halestrap et al., 2007; Dirnagl et al., 2008). The molecular mechanisms 
underlining these effects are still the objects of investigation. Nitrite and 
protein kinases have been proposed as possible MPTP regulators (Zhao et 
al., 2006; Shiva et al., 2007). 
The hypothesis that a modulation of the expression and activity of the sodium 
calcium exchanger (NCX) might play a role in the regulation of calcium and 
sodium homeostasis during ischemic tolerance cannot be ruled out. Indeed, 
the Na+/Ca2+ exchanger, in parallel with selective ion channels and ATP 
dependent pumps, maintains the physiological cytosolic concentrations of 
these ions (Blaustein and Lederer, 1999). In the brain, unlike other tissues, 
this exchanger is present in 3 different gene products, named NCX1, NCX2, 
and NCX3, with a distinct distribution pattern in different brain regions 
(Canitano et al., 2003). Under physiological conditions, its primary role is to 
extrude Ca2+ through a forward mode of operation in response to a 
depolarization or to an increase in intracellular Ca2+ concentrations coupled 
to receptor stimulation. However, during hypoxic conditions, owing to the 
compromission of the 2 plasma-membrane ATP-dependent pumps Na+/K+ 
ATPase and Ca2+ ATPase, NCX assumes a relevant role in controlling the 
intracellular homeostasis of these two cations since is able to operate in the 
reverse mode, thus extruding Na+ ions while promoting Ca2+ influx 
(Annunziato et al., 2004). Although this reverse mode of operation in the 
early phase of anoxia does undoubtedly elicit an increase in [Ca2+]i, its effect 
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could be beneficial for neurons because it contributes to decrease [Na+]i 
overload, a phenomenon which would otherwise lead to cell swelling and, 
thus, sudden necrotic neuronal death. Conversely, in the later phase of 
neuronal anoxia, when [Ca2+]i overload takes place, NCX working in the 
forward mode can contribute to the lowering of Ca2+ concentrations, and thus 
can protect neurons from Ca2+ intracellular overload, neurotoxicity and 
subsequent cell death. A new emerging concept is that NCX1, NCX2, and 
NCX3 may exert different roles during in vitro and in vivo anoxic conditions. 
Indeed, in cells singly and stably transfected with NCX3, this isoform 
contributes more significantly to the maintenance of [Ca2+]i homeostasis 
during experimental conditions mimicking ischemia, thereby preventing 
mitochondrial ΔΨ collapse and cell death (Secondo et al., 2007). In addition, 
in in vivo experiments, the selective knocking down of NCX1 and NCX3, but 
not of NCX2, by antisense oligodeoxynucleotide strategy, (Pignataro et al., 
2004) or the disruption of the ncx3 gene, renders the brain more susceptible 
to the ischemic insult (Molinaro et al., 2008). Moreover, the induction of 
permanent middle cerebral artery occlusion in rats, correlates with NCX1 
mRNA upregulation in the peri-infarct area thus suggesting the possibility that 
this isoform could be a new druggable target for the treatment of cerebral 
ischemia. In line with this hypothesis, we recently demonstrated that NCX1 
transcript and protein were up-regulated by ischemic cerebral 
preconditioning. This effect was mediated by the transcriptional factor HIF1 a 
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and  was accompanied by a relevant neuroprotective effect (Valsecchi et al., 
2011). 
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AIM OF THE STUDY 
 
Since several players are involved in the complex molecular events 
implicated in ischemic tolerance, the aim of this study was to identify whether 
the sodium-calcium exchanger might play a role in the neuroprotection 
induced by cerebral ischemic preconditioning through the regulation of 
intracellular ionic homeostasis. 
To address this issue a model of hypoxia/reoxygenation was set up in vitro 
by exposing cortical neurons to 3 hours of combined oxygen and glucose 
deprivation (OGD) followed by subsequent 24 hr exposure to normoxic 
conditions (reoxygenation), which represented the severe insult. The sub-
lethal preconditioning stimulus was reproduced by exposing neurons to 30 
minutes of OGD, 24 hours before the lethal insult. 
After these treatments, experiments were conducted to detect the rate of 
neuronal survival by using propidium iodide (PI) and fluorescein diacetate 
(FDA) assay. The amount of cell death was determined measuring the ratio 
between the number of PI positive- dead cells compared to the total number 
of cells (PI and FDA positive cells) (Wei et al. 2000). The results showed that 
the preconditioning stimulus did not impair neuronal survival and prevented 
neuronal death induced by OGD/reoxygenation. Once demonstrated the 
neuroprotective effect of ischemic preconditioning, a further aim of the study 
was to investigate the molecular and cellular events involved in the regulation 
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of this phenomenon. In particular, the attention was addressed to the role of 
Na+/Ca2+ exchanger (NCX). Therefore, the expression and activity of the 
three NCX isoforms was evaluated by Western Blot analysis,  confocal 
microscopy and single cell microfluorimerty. 
The results obtained demonstrated that NCX1 and NCX3 protein expression 
increased in neurons exposed to the sub-lethal insult within 48 hours, an 
effect that was observed even when ischemic preconditioning was applied to 
neurons exposed to OGD/reoxygenation, suggesting the possibility that this 
effect could be positively correlated with the development of tolerance. 
Interestingly, the rise in NCXs protein expression occurring during IPC was 
related to the over-activity of the nNOS synthase and NO production which in 
turn stimulated Akt activation. Indeed, the treatment with L-NAME and 
LY294002, well known inhibitors of nNOS and PI3 kinase respectively 
prevented NCX3 IPC-induced overexpression. Conversely, the effect of IPC 
on NCX1 expression was counteracted by LY294002 pretreatment, but was 
not affected by L-NAME. On the other hand, the activation of Akt observed 
after IPC was inhibited by the treatment with L-NAME, thus supporting the 
hypothesis that PI3K/akt/NO pathway could play a role in the regulation of 
NCX1 and NCX3 protein expression in the IPC phase.  
To understand the functional implication of NCXs protein expression in the 
IPC-induced neuroprotection, the activity of the exchanger was evaluated by 
single cell microfluorimetry. The results showed an increase in NCX activity 
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in the reverse mode of operation in neurons exposed to IPC that was still 
detected in preconditioned neurons exposed to OGD/Reoxygenation. This 
raised activity did not affect cytosolic calcium concentration but promoted 
ER-calcium refilling. Interestingly, the treatment with siRNA against NCX1 
and L-NAME abolished this effect, suggesting the importance of this isoform 
in the regulation of ER calcium content in a NO dependent manner. 
Conversely, the treatment with siRNA against NCX3 induced an increase in 
ER calcium content detectable 30 minutes, 24, and 48 hrs after the IPC 
stimulus. However, as a reduction in NCX activity was observed after the 
treatment with siNCX3 as well, the role of NCX3 as possible player in the 
regulation of mitochondrial calcium concentration ([Ca2+]m) during IPC was 
also investigated. To address this issue, [Ca2+]m was measured, by confocal 
microscpy and single cell microfluorimetry, in neurons treated with siNCX3 
and exposed to IPC and IPC followed by OGD/reoxygenation. The results 
obtained with this experimental approach suggested that NCX3 during IPC 
contributes to the regulation of [Ca2+]m which results lower compared with 
that observed in control neurons or in neurons exposed to 
OGD/reoxygenation. This effect was more pronounced 48 hrs after IPC 
stimulus and was not affected by the treatment of neurons with siRNA 
against NCX1. Moreover, during IPC, the treatment of neurons with 
CGP37157 slightly modifies NCX3 activity on mitochondria inducing an 
increase in mitochondrial calcium concentration. Interestingly, this effect was 
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related to an impairment of mitochondrial oxidative capacity during IPC 
whereas, in the absence of the mNCX inhibitor this sub-lethal insult did not 
affect mitochondrial function. 
Finally, to correlate the role of the NCX isoforms 1 and 3 with the 
neuroprotection occurring in the ischemic brain tolerance, we assessed 
neuronal survival in the presence of siRNAs against NCX1 and NCX3. These 
treatments resulted in an increase of neuronal death after preconditioning 
insult whereas such stimulation in the absence of treatment did not affect cell 
viability. 
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MATERIALS AND METHODS 
 
Primary culture of cortical neurons 
Cortical neurons were prepared from brains of 16-day-old Wistar rat embryos 
(Charles River) and used at 7 to 10 days in vitro for protein expression 
analysis. Briefly, dissection and dissociation were performed in Ca2+/Mg2+-
free phosphate-buffered saline containing glucose (30 mmol/L). Tissues were 
incubated with papain for 10 minutes at 37°C and dissociated by trituration in 
Earl‘s balanced salt solution containing DNAse (0.16 U/mL), bovine serum 
albumin (10 mg/mL), and ovomucoid (10 mg/mL). Cells, plated in plastic Petri 
dishes 100 mm diameter with a confluence of 15x106 (Falcon; Becton-
Dickinson) precoated with poly-D-lysine (20 g/mL), were grown in MEM/F12 
containing glucose, 5% of deactivated fetal bovine serum, and 5% horse 
serum, glutamine (2 mmol/L), penicillin (50 U/mL), and streptomycin (50 
g/mL; Invitrogen). To carry out single cell videoimaging and confocal 
microscopy, cultures of cortical neurons were prepared as described 
previously (Abramov et al., 2007) with modifications, from Wistar rat pups 2–
4 days postpartum. The tissue was minced and trypsinized (0.1% for 15 min 
at 37°C), triturated, and plated on poly-D-lysine-coated coverslips and 
cultured in Neurobasal medium (Invitrogen) supplemented with B-27 
(Invitrogen) and 2mM L-glutamine. Cells were plated at concentration of 
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1.8x106 on 25-mm glass coverslips. Cultures were maintained at 37°C in a 
humidified atmosphere of 5%CO2 and 95% air, fed twice a week, and 
maintained for a minimum of 10 days before experimental use.  
 
Combined oxygen and glucose deprivation (OGD) 
In cortical neurons, OGD insult was reproduced in vitro by exposing cells to a 
medium previously saturated with 95% N2 and 5% CO2 for 20 min and 
containing (in mmol/L) 116 NaCl, 5.4 KCl, 0.8 MgSO4, 26.2 NaHCO3, 1 
NaH2PO4, 1.8 CaCl2, 0.01 glycine, and 0.001 wt/vol phenol red (Scorziello 
et al., 2004). Hypoxic conditions were maintained using a hypoxia chamber 
(Billups Rothemberg Inc; temperature 37°C, atmosphere 5% CO2, and 95% 
N2) for 3 hours. Then, following their removal from the hypoxic chamber, they 
were challenged with a culture medium containing glucose and previously 
saturated with a mixture of 95% O2 and 5% CO2 for 10 min. Thus, 
reoxygenation (Rx) was achieved by returning neurons to normoxic 
conditions (5% CO2 and 95% air) for 24 h. 
Instead, the preconditioning stimulus was reproduced by exposing neurons to 
30 minutes of OGD. 
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Western Blot 
Protein samples (50 g) were analyzed on 8% sodium dodecyl sulfate 
polyacrilamide gel with 5% sodium dodecyl sulfate stacking gel (SDS-PAGE) 
and electrotransferred onto Hybond ECL nitrocellulose paper (Amersham). 
Membranes were blocked with 5% nonfat dry milk in 0.1% Tween 20 (TBS-T; 
2 mmol/l Tris–HCl, 50 mmol/l NaCl, pH 7.5) for 2 h at RT and subsequently 
incubated overnight at 4 °C in the blocked buffer with the 1:1000 antibody for 
NCX1 (polyclonal rabbit antibody, Swant); 1:5000 antibody for NCX3 
(polyclonal rabbit antibody, Philipson laboratory); 1:1000 antibody for Akt and 
pAKT (polyclonal rabbit antibody); 1:1000 antibody for -actin (monoclonal 
antibody, Sigma). The membranes were washed with 0.1% Tween-20 and 
incubated with the secondary antibodies for 1 h (1:5000 NCX3 and 1:1000 
NCX1; Amersham). Immunoreactive bands were detected with the ECL 
(Amersham). The optical density of the bands was determined by Chemi Doc 
Imaging System (Biorad). 
 
Imaging mitochondrial Ca2+ and mitochondrial membrane potential 
Mitochondrial calcium concentration ([Ca2+]m) was assessed using the 
fluorescent dye X-Rhod1. Cells were loaded with X-Rhod1 0.2 M for 15 min 
in a medium containing 156 mM NaCl, 3 mM KCl, 2 mM MgSO4, 1.25 mM 
KH2PO4, 2 mM CaCl2, 10 mM glucose, and 10 mM Hepes. The pH was 
adjusted to 7.35 with NaOH. At the end of the incubation, cells were washed 
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3 times in the same medium. An increase of mitochondrial localized intensity 
of fluorescence was indicative of mitochondrial Ca2+ overload.  
Mitochondrial membrane potential was assessed using the fluorescent dye 
tetramethyl rhodamine ethyl ester (TMRE) in the ―redistribution mode‖. Cells 
were loaded with TMRE (20 nM) for 30 min in the above described medium. 
At the end of the incubation, cells were washed in the same medium 
containing TMRE (20 nM) and allowed to equilibrate. A decline of 
mitochondria-localized intensity of fluorescence was indicative of 
mitochondrial membrane depolarization. 
Confocal images were obtained using a Zeiss inverted 510 confocal laser 
scanning microscopy and a 63X oil immersion objective. The illumination 
intensity of 543 Xenon laser, used to excite X-Rhod-1 fluorescence, was kept 
to a minimum of 0.5% of laser output to avoid phototoxicity.  
 
[Ca2+]i measurment 
[Ca2+]i was measured by single cell computer-assisted videoimaging 
(Secondo et al., 2007). Briefly, cells, grown on glass coverslips, were loaded 
with 5 M Fura-2 acetoxymethyl ester (Fura-2AM) for 30 min at room 
temperature in normal Krebs solution containing (in mM): 5.5 KCl, 160 NaCl, 
1.2 MgCl2, 1.5 CaCl2, 10 glucose, and 10 Hepes–NaOH, pH 7.4. At the end 
of the Fura-2AM loading period, the coverslips were placed into a perfusion 
chamber (Medical System, Co. Greenvale, NY, USA) mounted onto a Zeiss 
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Axiovert 200 microscope (Carl Zeiss, Germany) equipped with a FLUAR 40X 
oil objective lens. The experiments were performed as previously reported 
(Secondo et al., 2007). The amount of Ca2+ extruded in the cytoplasm upon 
FCCP exposure was measured as [Ca2+]i increase. This release is widely 
considered as an index of mitochondrial Ca2+ efflux. 
 
Determination of cell death: Propidium iodide/Fluorescein assay 
Neuronal death was evaluated by measuring the ratio between dead and 
living cells. To quantify cell death after the experimental procedures, the cells 
were washed with normal Krebs and double stained with 36M Fluorescein 
Diacetate (FDA) and 7M Propidium Iodide (PI) for 5 min at 37°C in a 
phosphate buffer solution. Stained cells were examined immediately with a 
standard inverse fluorescence microscope at 480 nm and 546 nm (Secondo 
et al 2007). PI- and FDA-positive cells were counted in three representative 
high power fields of independent cultures and cell death was determined by 
the ratio of the number of PI positive cells/PI + FDA-stained positive cells 
(Wei et al 2000). 
 
Determination of mitochondrial function: MTT assay 
Neuronal survival was assessed by using 3-(4,5-dimethylthiazol-2-yl)-2,5, 
diphenyltetrazolium bromide (MTT) (Hansen et al. 1989; Amoroso et al. 
1999). The assay was based on the red-ox ability of living mitochondria to 
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convert dissolved MTT into insoluble formazan. Briefly, after treatments, the 
medium was removed and cells were incubated in 2 mL of MTT solution (0.5 
mg/mL) for 1 h in a humidified 5% CO2 incubator at 37_C. To stop 
incubation, MTT solution was removed and 1 Ml dimethyl sulfoxide was 
added to solubilize the formazan product. The absorbance was monitored at 
540 nm with a Perkin-Elmer LS 55 luminescence spectrometer (Perkin-Elmer 
Ltd, Beaconsfield, England). The data are expressed as percentage of cell 
viability compared to sham-treated cultures. 
 
Small interfering RNA against NCX1 AND NCX3 
The mammalian expression vector, pSUPER.retro.puro (Oligo-Engine), was 
used to express siRNA against NCX1 (siRNA-NCX1; NM_019268) in cortical 
neurons. To prepare siRNA-NCX1, a 60-base oligonucleotide and another 
oligonucleotide with the complementary sequence were annealed and 
inserted into pSUPER.retro.puro as previously reported by Formisano et al. A 
mismatch sequence cloned in the same vector was used as an experimental 
control. To express siRNA against NCX3, the gene-specific insert contained 
a 19-nucleotide sequence corresponding to the coding region +124 to +142 
relative to the first nucleotide of the start codon of rat NCX3 (GenBank 
accession no. U53420), whose specificity was verified by BLAST, was used. 
A mismatch sequence cloned in the same vector and pSUPER.retro.puro 
vector itself were used as experimental controls. 
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After 72 hours‘ plating, cortical neurons were transfected with siRNA-NCX1, 
siRNA-NCX3 or siRNA mismatch in OPTIMEM by means of lipofectamine 
LTX (Invitrogen). After 5 hours, it was replaced with fresh medium. 
 
Materials 
All the reagents were purchased from Sigma Chemicals (Milan Italy), unless 
otherwise specified. LY294002 was supplied by Calbiochem (Inalco, Milan, 
Italy). L-NAME (500 lmol/L) and PD98059 (25 lmol/L) were present in the 
medium 30 min before exposure to IPC and during the IPC phase. 
 
Statistical analysis 
Western blot analyses were repeated three times. All the other experiments 
were performed in triplicate and repeated at least three times. Data were 
expressed as mean ± SEM values and as percentages of basal values. 
Statistical significance among the means was determined by the ANOVA 
followed by the Newman–Keuls test. A p-value <0.05 was considered 
statistically significant. 
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RESULTS 
 
Effect of ischemic preconditioning on neuronal survival of cortical 
neurons exposed to OGD/REOXYGENATION 
 
The exposure of cortical neurons to 30 minutes of OGD, a condition that is 
comparable to a sublethal ischemic insult and commonly defined as ischemic 
preconditioning (IPC), did not affect neuronal survival.  3 hours of OGD 
followed by 24 hours of reoxygenation, representing the lethal insult, caused 
an increase in neuronal death. However, this effect was thwarted when the 
cells were pre-exposed, 24 hours before the lethal insult, to IPC followed by 
24 hours of reoxygenation. (Figure 1). 
 
 
 
 
 
 
 
 
Figure 1: Effect of ischemic preconditioning on neuronal survival of cortical neurons 
exposed to OGD/REOXY: cortical neurons (12 DIV) were exposed to IPC (30 min di OGD) 
followed by 24 hrs of normoxia, and then to 3 hrs of OGD followed by 24 hrs of 
reoxygenation. Cell viability was measured by propidium iodide and fluorescein diacetate 
assay at the end of reoxygenation. *P<0.05 vs CTL and IPC. **P<0.05 vs OGD/Reoxy. 
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NCX1 and NCX3 protein expression after ischemic preconditioning in 
cortical neurons exposed to OGD/REOXYGENATION 
 
The exposure of cortical neurons to IPC followed by 48 hours of 
reoxygenation determined a significant increase in NCX1 (Figure 2A) and 
NCX3 (Figure 2B) protein expression. The same increase was observed in 
neurons exposed to 3 hrs of OGD preceded, 24 hours before, by a sublethal 
insult followed by 24 hours of normoxia. These results create the conditions 
to investigate first the molecular mechanisms underlying the NCX1 and 
NCX3 increased expression, and to understand if this increase is positively 
related to the neuroprotection induced by cerebral ischemic preconditioning. 
 
 
 
 
 
 
 
Figure 2: NCX1 e NCX3 expression after IPC in cortical neurons exposed to 
OGD/REOXY: cortical neurons exposed to IPC followed by 24 hrs of normoxia, and to 3 hrs 
of OGD followed by 24 hrs of reoxygenation. Protein expression was evaluated by western 
blotting at the end of reoxygenation (A) NCX1 expression. (B) NCX3 expression. *P<0.05 Vs 
CTL and OGD/REOXY. 
 
IPC
+
48h
REOXY
IPC 
+ 
OGD 
REOXY
IPC
+
48h
REOXY
IPC 
+ 
OGD 
REOXY
NCX1
120 KDa
Actin
42 KDa
N
C
X
3
/A
c
ti
n
%
 o
f 
C
o
n
tr
o
l
NCX3
105 KDa
Actin
42 KDa
0
OGD 
REOXY
CTL
*
20
40
60
80
100
120
140
160
180
N
C
X
1
/A
c
ti
n
%
 o
f 
C
o
n
tr
o
l
*
0
OGD 
REOXY
CTL
20
40
60
80
100
120
140
160
180
*
**
*
N
C
X
3
/A
c
ti
n
%
 o
f 
C
o
n
tr
o
l
N
C
X
1
/A
c
ti
n
%
 o
f 
C
o
n
tr
o
l
A B
76 
 
Akt activation in cortical neurons exposed to IPC 
 
The exposure of cortical neurons to IPC yielded a significant increase in 
phosphorylated, therefore activated, Akt expression. In order to understand if 
the biochemical mechanisms responsible for this rise were related to the 
increased nitric oxide (NO) production induced by IPC, Akt activation was 
explored after the treatment with L-NAME, a well known NOS inhibitor 
(Knepper and Kurylo 1998). The results demonstrated that this treatment was 
able to induce a significant decrease in pAkt expression (Figure 3), 
suggesting a role of NO in the regulation of Akt activity in ischemic tolerance. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Effect of IPC and NOS inhibition on Akt activation: cortical neurons (12 DIV) 
were exposed to IPC (30 min OGD) with and without L-NAME. Protein expression was 
evaluated by western blotting at the end of IPC stimulus. *P<0.05 Vs CTL and IPC+L-NAME. 
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NCX1 and NCX3 expression after LY294002 and L-NAME treatment in 
cortical neurons exposed to IPC 
 
To correlate the increase in the expression of NCX1 and NCX3 observed in 
cortical neurons exposed to IPC with the rise in NO production and the 
activation of Ras/IP3/Akt pathway, the expression of the above mentioned 
proteins was investigated in cortical neurons treated with LY294002 
(8mol/L), a well known IP3-kinase inhibitor, and L-NAME (500 mol/L) 
before the exposure to a subletlal insult. The data confirmed that LY294002 
was able to reduce significantly the NCX1 expression, whereas L-NAME did 
not affect its expression (Figura 4A). Instead, both LY294002 and L-NAME 
were able to reduce NCX3 expression (Figura 4B), suggesting that the two 
different isoforms of NCX might be target of the transductional Ras/IP3/Akt 
pathway activated by NO, probably through different mechanisms. 
 
 
 
 
 
 
 
 
Figure 4: NCX1 and NCX3 expression after the treatment with LY294002 and L-NAME: 
cortical neurons exposed to IPC and treated with LY294002 and L-NAME. Protein 
expression was evaluated by western blotting.(A) NCX1 expression. (B) NCX3 expression. 
*P<0.05 Vs CTL; **P<0.05 Vs IPC. 
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NCX activity after ischemic preconditioning in cortical neurons exposed 
to OGD/REOXYGENATION 
 
Parallel studies have been conducted to assess NCX activity during ischemic 
tolerance. The experiments were carried out by using single cell 
microfluorimetry with the fluorescent probe Fura-2AM. The results obtained 
demonstrated an early increase in NCX activity in the reverse mode of 
operation in cortical neurons exposed to IPC and IPC followed by 
OGD/Reoxygenaton. Since this increased activity did not affect [Ca2+]i, it has 
been hypothesized that the increase in NCX activity observed during IPC 
could be related with endoplasmic reticulum (ER) Ca2+ refilling. To this aim, 
cortical neurons exposed to 30 min of IPC were loaded with Fura-2AM and 
stimulated with a solution containing thapsigargin to induce a massive 
calcium release from intracellular IP3 sensitive calcium stores. By this 
approach, it was possible to verify that the calcium content in the ER is 
higher in cortical neurons exposed to IPC compared to non preconditioned 
neurons (Figure 5A). Since it has been demonstrated that NCX1 plays a role 
in ER Ca2+ refilling and this is considered a protective mechanism able to 
prevent apoptotic death associated to ER stress (Sirabella et al. 2009), the 
hypothesis that NCX1 might regulate the entry of calcium into endoplasmic 
reticulum during the preconditioning was investigated. To verify this 
hypothesis the experiments described above were performed in presence of 
siRNA against NCX1 and NCX3. The results demonstrated that only the 
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siNCX1 was able to prevent ER Ca2+ refilling during ischemic 
preconditioning. Moreover, the same effect was observed after the 
pretreatment of neurons with L-NAME (Figure 5B), thus suggesting again 
that NCX1 has a crucial role to prevent neuronal death during ischemic 
preconditioning by stimulating ER calcium refilling, probably in a NO 
dependent manner. The involvement of NCX1 in the regulation of ER calcium 
content is an early event since it was detectable within 24hr by the IPC 
stimulus time in which the amount of calcium into ER is higher when 
compared with that observed in control neurons.  Conversely, 48 hrs after 
IPC the amount of calcium into the ER was similar to that observed in the 
control cells. Interestingly, siRNA against NCX3 induced an increase in ER 
calcium content both after 30 minutes and after 24 and 48 hrs after the IPC 
stimulus. In these conditions it is possible to speculate that the impairment of 
NCX3 activity working in the forward mode of operation, leads to the increase 
of intracellular calcium content, further contributing to NCX1-induced ER 
calcium refilling. The treatment of cortical neurons with CGP37157, the 
inhibitor of the mitochondrial sodium calcium exchanger, during IPC further 
supports this hypothesis. Indeed, in these experimental conditions the 
amount of calcium content in the ER was comparable to that observed in the 
untreated cells, thus excluding the involvement of NCX3 in the regulation of 
ER calcium refilling (Figure 5C).  
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Figure 5: Effect of IPC on NCX activity and ER Ca2+ refilling: (A) cortical neurons 
exposed to IPC, followed by 24 and 48 hrs of normoxia and to 3 hrs of OGD followed by 24 
hrs of Reoxygenation. [Ca
2+
]i, NCX activity and ER calcium release, after tapsigarghin 
stimulation, were evaluate at the end of the treatments. *P<0.05 Vs CTL; (B) effect of 
siNCX1and L-NAME on NCX activity and Ca
2+
 release from ER. *P<0.05 Vs CTL; **p<0.05 
Vs IPC 30 min. (C) effect of siNCX3 and CGP on Ca
2+
 release from ER. *P<0.05 Vs CTL; 
**p<0.05 Vs not silenced neurons; **p<0.005 Vs IPC+24h reoxy and IPC+48h reoxy. 
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[Ca2+]m in cortical neurons treated with siRNA against NCX3 and 
exposed to OGD/REOXYGENATION 
 
Since the previous experiments demonstrated that NCX3 knocking down 
impairs NCX activation during IPC and stimulate ER calcium refilling, the next 
experiment was addressed to understand how NCX3 could contribute to this 
phenomenon. On the basis of data obtained from our research group 
showing that NCX3 is the only isoform present on mitochondria where it 
plays a key role in the mitochondrial calcium handling, and considering that 
mitochondria work in concert with ER in the regulation of intracellular calcium 
homeostasis, we performed experiments aimed to evaluate the contribution 
of NCX3 in the regulation of mitochondrial calcium concentration in cortical 
neurons exposed to ischemic preconditioning. The results showed an 
increase in mitochondrial calcium concentrations after the silencing of NCX3, 
whereas the exposure of neurons to the only IPC stimulus was able to 
reduce significantly the calcium levels, even when exposed to 3 hours of 
OGD followed by 24 hours of reoxygenation (Figure 6A). These data, 
obtained by using confocal microscopy and the fluorescent probe X-Rhod1, 
were confirmed with single cell microfluorimetry experiments. To this aim, 
neurons exposed to IPC were loaded with Fura 2 and then treated with 
FCCP uncoupler (250 nM) to induce mitochondrial depolarization and Ca2+ 
extrusion. The amount of Ca2+ extruded in the cytoplasm is considered an 
index of mitochondrial Ca2+ content. The results obtained with this 
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experimental approach suggested that NCX3 during IPC contributes to the 
regulation of [Ca2+]m which results lower when compared with that observed 
in control neurons or in neurons exposed to OGD/reoxygenation (Figure 6B). 
Interestingly, this effect was not affected by the treatment of neurons with 
siRNA against NCX1 (Figure 6C). To further support the hypothesis that 
NCX3 on the outer mitochondrial membrane participate to mitochondrial 
calcium handling during IPC, neurons were treated with CGP37157 during 
IPC and mitochondrial calcium concentrations was measured by confocal 
microscopy. The results of this experiments demonstrated that CGP37157 
significantly affects NCX3 activity inducing an increase in mitochondrial 
calcium concentration (Figure 6C). 
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Figure 6: [Ca
2+
]m in cortical neurons treated with siNCX3 and exposed to IPC/OGD 
followed by reoxygenation: (A) [Ca
2+
]m evaluated by using confocal microscopy with the 
fluorescent probe X-Rhod1 in neurons (12 DIV) exposed to IPC, followed by 24 and 48 hrs of 
normoxia and to 3 hrs of OGD followed by 24 hrs of reoxygenation. (B) [Ca
2+
]m evaluated by 
using single cell microfluorimetry with the probe Fura-2AM after the treatment with FCCP in 
cortical neurons exposed to IPC, followed by 24 e 48 hrs of normoxia and then to 3 hrs of 
OGD followed by 24 hrs of reoxy. [Ca
2+
]m were measured at the end of the treatmens. *P<0.05 
Vs CTL; # P<0.05 Vs its not treated CTL. (C) effect of siNCX3 and CGP on  [Ca
2+
]m in 
neurons exposed to IPC followed by 48 hrs of normoxia and treated with siNCX1 and CGP. 
*P<0.05 Vs CTL; # P<0.05 Vs IPC+48h reoxy. 
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Mitochondrial function in cortical neurons treated with CGP and 
exposed to IPC followed by OGD/REOXYGENATION 
 
To understand whether the variations observed in mitochondrial calcium 
concentrations could be responsible for the neuroprotection induced by 
cerebral ischemic preconditioning, cell viability was assessed in terms of 
mitochondrial function after treatment with CGP, in cortical neurons exposed 
to IPC. The data showed a worsening in the mitochondrial function in 
neurons exposed to IPC insult after this treatment, whereas the sublethal 
insult, in the absence of CGP, did not affect mitochondrial function. 
Moreover, the significant improvement in mitochondrial activity observed in 
preconditioned neurons exposed to OGD followed by reoxygenation was 
abolished by treatment of cells with CGP (Figure 7). To rule out the possibility 
that CGP effect might be related to a modification of mitochondrial membrane 
potential and not to a real inhibition of mitochondrial exchanger, 
mitochondrial membrane potential was measured by using TMRE fluorescent 
probe in CGP-treated neurons exposed to IPC and IPC followed by 
OGD/Rexoygenation. The results demonstrated that CGP did not affect 
mitochondrial membrane (Figure 7, inset).  
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Figure 7: Mitochondrial function in cortical neurons treated with CGP and to 
IPC followed by OGD/Reoxygenation: cortical neurons exposed to PC followed by 
OGD/REOXY after the treatment with CGP. Mitochondrial function was measured by using 
MTT assay at the end of reoxygenation. *P<0.05 Vs CTL e IPC; # P<0.05 Vs no CGP 
treatment. (7 Inset) Mitochondrial membrane potential in cortical neurons exposed to 
IPC/OGD reoxygenation after the treatment with CGP *P<0.05 Vs CTL; **P<0.05 Vs OGD 
reoxy. 
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Effect of ischemic preconditioning on neuronal viability of cortical 
neurons treated with siRNA against NCX1 and NCX3 and exposed to 
OGD/REOXYGENATION 
 
To further support the hypothesis that both NCX1 and NCX3, by regulating 
ER and mitochondrial calcium content, may be among the effectors 
responsible for the tolerance induced by cerebral ischemic preconditioning, 
neuronal viability was evaluated after the silencing of the two Na+/Ca2+ 
exchanger isoforms. The data obtained demostrated that after these 
treatments there was a significant increase in cell death in cortical neurons 
exposed to the only IPC stimulus, whereas this sublethal insult did not affect 
neuronal survival but rather was able to protect neurons from death induced 
by OGD/Reoxygenation. Moreover, the treatment with siRNA against both 
NCX1 and NCX3 prevented the neuroprotective effect of ischemic 
preconditioning in cortical neurons exposed to a subsequent OGD followed 
by 24 hours of reoxygenation (Figure 8). 
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Figure 8: Effect of IPC on neuronal servival of cortical neurons treated with siNCX1 
and siNCX3and exposed to OGD/Reoxy: cortical neurons (12 DIV) were expesed to IPC 
(30 min di OGD) followed by 24 hrs of normoxia, and then to 3 hrs of OGD followed by 24 
hrs of reoxygenation with and without the silencing against NCX1 and NCX3. Cell viability 
was measured by propidium iodide and fluorescein diacetate assay at the end of 
reoxygenation. *P<0.05 Vs CTL and IPC; **P<0.05 Vs OGD/REOXY; #p<0.05 Vs cx not 
silenciated. 
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DISCUSSION 
 
The results of the present study demonstrated that the two isoforms of the 
Na+/Ca2+ exchanger, NCX1 and NCX3, which are involved in several 
pathophysiological aspects of cerebral ischemia, can be included among the 
members of the growing family of the mediators involved in the ischemic 
brain tolerance due to their ability to regulate neuronal calcium homeostasis. 
In particular, we proved evidence that neuroprotection observed in 
preconditioned neurons exposed to OGD/reoxygenation was correlated to 
the increase in NCX1 and NCX3 protein expression. Indeed, the treatment 
with siRNA against NCX1 and NCX3 was able to prevent this effect. These 
data are in accordance with results recently observed in vivo in an animal 
model of ischemic preconditioning (Pignataro et al., 2011). Consistently with 
these results we found that the upregulation of NCX1 and NCX3 protein 
expression in neurons exposed to IPC was dependent on PI3K/Akt 
activation, since the treatment with LY294002 was able to abolish this 
increase. Interestingly, in our experimental model,  we demonstrated that NO 
plays a key role in the triggering PI3K/Akt pathway as the increase in the 
phosphorylated form of Akt observed within 30 minutes after IPC was 
completely abolished by the treatment with L-NAME. More importantly, the 
treatment with L-NAME was able to inhibit NCX3 but did not affect NCX1 
protein expression. We recently demonstrated that in neurons NCX3, apart 
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its localization on the plasmamembrane, is also expressed on the outer 
mitochondrial membrane where it contributed to the extrusion of calcium from 
mitochondria (Scorziello et al., submitted paper). It is well known that 
mitochondria, in addition to the generation of cellular energy, play an 
important role in regulating cellular calcium homeostasis (Babcock et al., 
1997; Budd and Nicholls, 1996; Werth and Thayer, 1994; Jouaville et al., 
1995) in concert with the sarco-endoplasmic reticulum Ca2+-ATPase, the 
plasma membrane Ca2+-ATPase and Na+/Ca2+ exchanger (Saris and 
Carafoli, 2005). On the other hand, the maintenance of mitochondrial calcium 
homeostasis is an important requirement ensuring mitochondrial function. In 
fact, Ca2+-sensitive dehydrogenases can regulate oxidative phosphorylation 
and ATP synthesis during times of high cellular demand (McCormack and 
Denton, 1980). Therefore it is possible to hypothesize that the increased 
expression of NCX3, within 48hrs from the sub-lethal insult, might exert 
neuroprotective effects regulating calcium handling and improving 
mitochondrial oxidative capacity. This finding is in line with the results 
previously obtained in an in vitro model of IPC and demonstrating that the 
increase in nNOS expression and NO• production through the activation of 
Ras/ERK1/2 pathway stimulated mitochondrial MnSOD. These effects were 
associated with a reduction in free radical production, cytocrome c release 
from mitochondria to cytosol, and in turn to an improvement of neuronal 
survival (Scorziello et al., 2007). On the basis of the tight correlation among 
91 
 
mitochondrial calcium content, oxidative metabolism and neuronal survival, 
the results of the present study add new insight to the molecular mechanisms 
involved in the ischemic brain preconditioning. Indeed, the over-expression of 
NCX3 might help mitochondria to preserve their energetic capacity making 
them less vulnerable to the subsequent lethal insult represented by 
OGD/reoxygenation. This hypothesis was strongly supported by the results 
obtained measuring the activity of NCX during IPC. In fact, we demonstrated 
that IPC induced an increase of NCX activity in the reverse mode of 
operation that was still observed in preconditioned neurons exposed to 
OGD/Reoxygenation. This is an early event since it occurred within 30 
minutes after IPC stimulus and is due to the contribution of NCX1 and NCX3 
isoforms and was promoted by NO because was abolished by the treatment 
with L-NAME.  Intriguingly, this effect was associated with an increase in ER 
calcium content. Consistently with data previously published (Sirabella et al., 
2009), the experiments of the present study suggested that NCX1, working in 
the reverse mode of operation, play a key role in the regulation of ER calcium 
refilling in the early phase of IPC. Indeed, the treatment with siNCX1, but not 
siNCX3, was able to prevent this phenomenon. The novel aspect of the study 
is the demonstration that NO promoted NCX1-induced ER refilling that was 
hampered by L-NAME pretreatment. This finding is in accordance with data 
recently published by Secondo et al., and demonstrating that NO was able to 
stimulate NCX1 to work in the reverse mode of operation, whereas NO did 
92 
 
not affect NCX3 activity (Secondo et al. 2011). The possibility that NCX1 
activation in the early phase of IPC could affect mitochondrial calcium 
content promoting mitochondrial calcium uptake could not be excluded. 
However, in the late phase of IPC mitochondrial calcium handling is mainly 
regulated by NCX3 that is able to promote mitochondrial calcium extrusion. 
This data is supported by the finding that NCX3 expression increased 48 hrs 
after the IPC insult. We have previously demonstrated that NCX3 is 
distributed also at mitochondrial level, therefore, it is possible to speculate 
that during IPC the increased expression of NCX3 on mitochondria might 
contribute to the efflux of calcium from mitochondria thus protecting neurons 
by the subsequent lethal OGD/reoxygenation. The finding that the treatment 
with CGP and siNCX3 counteracted the effect of IPC on mitochondrial 
calcium content leading to the lack of IPC-neuroprotection further supports 
this hypothesis.  
Collectively, we proposed a model (Figure 9) in which a functional interplay 
between NCX1 and NCX3 occurs during IPC. This phenomenon is tightly 
dependent on NO and Akt activation and, by contributing to the modulation of 
intracellular ionic homeostasis, could represent the mechanism responsible 
for neuroprotection induced by ischemic preconditioning. 
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Figure 9: Proposed model 
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